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Current preclinical research into traumatic brain injury focuses heavily upon cellular and
molecular testing to determine the effects of injury and potential benefits of
neuroprotective treatments. While this may be a useful method, some argue that an
increased focus on behavioral testing could lead to better clinical translation as these
assays assess the longer term, downstream effects from a brain injury. The most
characterized behavioral tests used in traumatic brain injury research are the spatial
learning and memory paradigms, Morris Water Maze and Barnes Maze. The Morris
Water Maze is the most used of theses paradigms and relies on spatial cues and a
platform for the escape from the water to measure spatial learning and memory but has a
downside in the endogenous anxiety because of the necessity of swimming. Additionally,
previous work with the Morris Water Maze showed issues in finding large differences
between injured and uninjured mice. The Barnes Maze offers an alternative to the Morris
Water Maze without the added stress caused by forced swimming by instead relying on
bright lights to encourage rodents into the dark escape area. Here, a novel shortened
Barnes Maze protocol has been developed and optimized to improve upon a traditional
Barnes Maze protocol in detecting differences between healthy and injured rodents.
Additionally, this protocol is used to assess the efficacy of a novel antioxidant

nanoparticle treatment. Through this testing, additional knowledge regarding the ability
and limitations of this experimental procedure are found as well as further knowledge
into the benefits shown by a neuroprotective treatment.
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CHAPTER 1: INTRODUCTION
From my previously published literature[1]:
Traumatic brain injury (TBI) is currently the leading cause of injury-related
morbidity and mortality worldwide, with an estimated global cost of USD 400 billion
annually [2]. Behavioral outcomes associated with TBI begin with primary injury to the
brain resulting from an externally applied force [3]. These external forces can originate
from direct contact between the brain and an object or through non-impact situations
including rotational acceleration and the energy waves produced from blasts [4, 5]. This
can result from falls, motor vehicle accidents, assault, domestic violence, military
warfare, and even recreational sports including football, hockey, and boxing [3]. These
multiple mechanisms of impact generate a broad spectrum of injury severities and
behavioral outcomes, leading to difficulties in developing diagnostic and prognostic
protocols, let alone effective treatments. Thus, there is still no approved therapy that has
shown efficacy in reducing the long-term secondary effects following TBI.
TBI patients have a 2–4-fold increase in the risk of developing dementia later in
life due to even a single instance of TBI followed by a loss of consciousness (LOC) [6].
In conjunction with aging, individuals who have experienced mild TBI are at increased
risk for developing Alzheimer’s disease, at 2.3 and 4.5 times more likely for moderate
and severe TBI, respectively [7]. Even repeated mild injuries, such as those among retired
professional American football players, have been correlated to long-term cognitive
deficits. Retired players who had suffered three or more concussions in their careers had
a 5-fold increase in mild cognitive impairments compared to their counterparts with no

history of concussions [6]. Additionally, Parkinson’s disease, amyotrophic lateral
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sclerosis (ALS), Creutzfeldt–Jakob disease, and chronic traumatic encephalopathy (CTE)
were also all found to be associated with the progression of chronic TBI [6]. Due to the
association of TBI with these progressive neurodegenerative diseases, viable treatment
options must be developed with an in-depth knowledge of the injury’s pathophysiology,
lest the current therapeutic stalemate continues.
Several safety precautions have been implemented to prevent head trauma,
including the provision and advancement of helmets, seatbelts, and airbags. However, the
major problem facing TBI patients is the spread of secondary corrosive damage to the
surrounding brain tissue following this initial impact. This lethal progression of
secondary damage is caused by a disruption in the oxidant/antioxidant equilibrium of the
brain, which forces a biochemical imbalance, leading to chronic oxidative stress [8].
Oxidative stress leads to the damage of lipids, proteins, and DNA in the brain and creates
deterioration similar to the development of some neurodegenerative diseases [8].
Oxidative stress progresses alongside a variety of other biochemical malfunctions,
including glutamate toxicity in neurons, mitochondrial dysfunction, and blood–brain
barrier (BBB) disruption [9]. Due to this secondary damage, TBI presents with a
multitude of physical, cognitive, and behavioral deficits. However, the evolution of these
deficits is highly variable and can range from minor concussive symptoms to severe TBI,
leading to probable death.
Unfortunately, differences among patients and their injuries provide a variety of
complications for medical personnel in determining efficient diagnoses and effective

treatments. From 1993 to 2016, there were 30 failed clinical trials involving various
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forms of treatment [10]. These treatment options included temperature control,
hypertonic saline, progesterone, prostacyclin, surgical intervention, intracranial pressure
monitoring, and various pharmacological therapeutics [10]. Although there has been
success in Phase II trials, all these treatments have failed during larger, multi-center
Phase III trials. These failures have resulted due to a variety of problems during testing
for the efficacy of treatments. Progesterone for the Treatment of Traumatic Brain Injury
(ProTECT) and Study of Neuroprotective Agent, Progesterone, in Severe Traumatic
Brain Injury (SyNAPse) both resulted in negative outcomes during Phase III trials [11].
Researchers postulate that these failures were the result of suboptimal dosing during
Phase II trials, suggesting inadequate delivery into the brain and poor target engagement,
in addition to heterogeneity between injuries [11]. Other clinical trials have had similar
issues, including problems with clinical trial design, lack of accurate injury phenotyping,
and inadequate outcome assessment tools [12]. Injury heterogeneity and inadequate
outcome assessment tools are capable of being mitigated with effective classification
systems. Classification systems have been previously constructed for categorizing the
injury severity of TBI in humans immediately following diagnostic exams from medical
professionals. Initial methods for classifying TBI in a clinical setting are efficient, but
simplistic in approach, leaving room for error between different degrees of human injury.
However, recent literature has investigated the most important variables for assessing
TBI in the hopes of improving upon the original designs to create a more effective
classification system [13, 14].

4

While methods for classifying degrees of injury in humans have advanced, efforts
have also been directed towards developing animal models for TBI to provide an
effective comparison to human injuries [15, 16]. These models have been used to
understand the pathophysiological mechanism for the progression of different degrees of
TBI. Additionally, animal models have aided in the development of potential treatments
for the reduction of oxidative stress, BBB dysfunction, and various other biochemical
impairments [9, 16]. Recently, Operation Brain Trauma Therapy (OBTT) was developed
as a multi-center, preclinical consortium to identify therapies that are beneficial in
alleviating damage from head trauma in animal models [12]. The OBTT makes use of
several animal models in three distinct injury categories, focal, diffuse, and non-impact
injury, creating a broad spectrum of potential pathophysiological outcomes [3, 16]. Each
model has unique procedures and outcomes in the hopes of providing a sufficient
translation to the variety of head traumas that occur in humans. Through these models,
comparisons can be derived between the various degrees of human injury severity, which
will ultimately lead to improvements in diagnostics and treatment protocols.
Additionally, these animal models can be used in conjunction with behavioral
assessments to identify the cognitive outcomes associated with different mechanisms of
injury. These behavioral tasks have been established to address a variety of neurological
changes associated with TBI, including deficits in spatial and non-spatial memory.
Additionally, impact to specific regions of the brain or spread of secondary injury could

result in emotional impairment and deficits in motor coordination, both present in clinical
presentations of TBI. In general, we see most of these deficits across all models;

however, behavioral outcomes are highly correlated with levels of injury severity, and
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repeated injuries result in variable changes in behavior [17].
SECTION 1.1: CLINICAL BEHAVIOR AND ANIMAL MODELS
In addition to the above understanding of TBI, it is important in describing and
communicating this research to note the specific behavioral consequences of TBI and the
corresponding animal model used throughout the following work. Clinically, TBI leads to
a variety of behavioral outcomes including chronic pain, anxiety, depression, aggression,
increased incidence of suicide, cognitive deficits, negative impacts to learning and
memory, and motor dysfunction [18-23]. While much preclinical TBI research focuses on
analysis using histology and biomarkers to determine the molecular mechanisms of
injury, behavioral testing has become more broadly utilized to determine how these
molecular changes may correlate to behavioral deficits. Some researchers believe that by
analyzing behavioral correlates, the transition between preclinical to clinical success may
be effectively bridged allowing for the creation of neuroprotective treatments and
enhanced rehabilitation [19]. Creating an effective paradigm measuring behavioral
deficits is clearly an important endeavor within the realm of preclinical TBI research with
clinical success in mind. However, another essential aspect in translating preclinical
research lies within the chosen animal model. While various animals, including monkeys,
swine, sheep, dogs, and cats are used, the most commonly used animals are rodents,
particularly rats and mice [16]. Though there are many methods for producing preclinical
TBI models, two of the most widely used are the fluid percussion injury (FPI) and the
controlled cortical impact (CCI) models [16]. While the FPI model has many benefits, the
CCI model is generally used more due to its reproducibility, highly controllable impact

depth, velocity, and time, lack of rebound injury, and its ability to accurately target a
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specific area of the brain [16, 19]. Indeed, the CCI model is currently the gold standard in
preclinical research and has been well characterized due to decades of use and its
similarity to human TBI, including blood-brain barrier (BBB) breakdown [24].
Breakdown of the BBB is an important aspect of TBI, especially in relation to targeted
treatment of TBI. With this breakdown, the permeability of the BBB increases
dramatically immediately following TBI allowing for intervention into the secondary
injury via systemic drug delivery [25]. Nanoparticles (NPs) are a valuable tool for taking
advantage of this window of opportunity and providing an effective treatment.
SECTION 1.2: NANOPARTICLE THERAPEUTICS
Research into NP treatments have expanded as many small molecule treatments
have failed in Phase III clinical trials, such as progesterone, tirilazad, and superoxide
dismutase [26, 27]. Many of these failed clinical trials hold common issues including two
areas of improvement: poor delivery and retention in the brain and toxicity away from the
targeted treatment area [28]. NPs are particularly suited to overcome these limitations as
they have been shown to accumulate and be retained within the area of injury up to 24
hours post-TBI, although with diminishing retention and accumulation the further from
the time of injury the NP injection is given [25, 28-30]. Various methods of
neuroprotection are used in NP treatment of TBI including antioxidant treatment of
oxidative stress, elimination of oxygen radicals, reduction of edema through delivery of
encapsulated Cerebrolysin, and delivery of brain-derived neurotrophic factor (BDNF)
[28]. Given this information, the potential of NPs as a method of TBI treatment is high
with many studies showing that NPs have effectively been able to either be a therapeutic
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themselves or deliver therapeutic molecules into the injured area with a higher amount of
accumulation and retention when delivered systemically than small molecule treatments.
SECTION 1.3: FORMS OF BEHAVIORAL ANALYSIS
There are a wide variety of behavioral assays one can use to assess behavioral
deficits related to TBI. These tasks can be categorized into four distinct groups: spatial
learning and memory, nonspatial learning and memory, emotional, and motor
coordination. From my previously published research [1]:
Spatial learning and memory are governed by the ability to navigate with two
forms, allocentric and egocentric navigation. Allocentric navigation is generally

described as using distal spatial cues to guide the direction of movement while egocentric
navigation relies more heavily on internal cues such as remembered sequence, speed, the
direction of movement, and utilizing closer cues referred to as “signposts”. Important in
the discussion of egocentric versus allocentric navigation is distinguishing between
“signposts” and “landmarks”. While they provide information for egocentric and
allocentric navigation, respectively, signposts do not provide any relational information.
Signposts simply convey where to change direction and do not aid in understanding
where one is in comparison to other signposts. In contrast, landmarks do not inherently
tell you where to change direction but can provide key information regarding one’s
placement in relation to other landmarks [31]. To better understand, think of signposts as
a particular intersection where you know to turn right to reach your location. Inversely,
one could also use the landmark of the street sign and the knowledge of the direction they
are approaching from to know to turn right in that situation. While these can sometimes

result in the same or similar choices, such as in this example, that is not always the case.
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For the sake of consistency, egocentric navigation will be covered as a form of nonspatial
navigation; therefore, our focus in this section is the allocentric aspects of each of these
paradigms despite the interconnected nature of the two forms of navigation. In order to
simplify this section, allocentric navigation will be the only form discussed within this
section as it focuses on hippocampal activity even though both allocentric (spatial) and
egocentric (nonspatial) navigation systems have an overlap in healthy brains [31].
As opposed to allocentric navigation, as described above, egocentric navigation is
a method of determining how to travel similarly to how one might go about a traditional
maze, using memory of motions made in conjunction with interior focal points to map
out the area mentally. This kind of navigation can be seen in patterns such as the serial
and non-spatial navigation shown in the Barnes Maze and Morris Water Maze. While this
can occur in many spatial learning tasks such as the Radial Arm Maze, certain variations
of spatial learning tasks can be altered to examine nonspatial learning and memory
specifically. While the overall administration of these tasks changes for the preclinical
models, clinical delayed non-match to sample and VR tasks can also be adjusted to
similar specifications to test nonspatial learning and memory.
Emotional changes in human TBI have been well documented. Despite this, many
of the tasks used to determine emotional deficits, such as anxiety-like behaviors, lead to
directly conflicting results depending entirely upon the paradigm, even within the same
procedures. These differences have yielded results determining both high and low levels
of anxiety in the same open field test along with equal anxiety when compared to

uninjured counterparts [32]. Many of these tests yield similar conflicts in TBI research.
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Additionally, human patients have reported near day-to-day variability in their levels of
anxiety, depression, and other emotional markers [33]. This may influence attempts to
find correlations between preclinical studies of TBI and clinical studies. However, many
of these models have been used for drug exploration in other realms such as
antidepressants, antianxiety, and other various psychopharmacological drugs. This may
redeem some of the criticisms these tasks have been given in the realm of TBI research,
though the innate variability of emotional deficits in TBI could also account for that
difference.
Motor coordination tasks, otherwise known as vestibulomotor tasks, measure the
coordination and physical differences between injured and uninjured rodents. These are
the most easily transitional tasks between clinical and preclinical studies as human TBI
has been shown to cause adverse effects, at least acutely, to motor coordination and
cognition [34].
Even larger than the sheer number of different ways to assess animal behavior are
the many data that can be gathered from these assessments. To simplify discussion
around data, their meaning, and what paradigms can assess which aspects of behavior,
Table 1 in the appendix has a thorough description of each datum, its relationship to TBI,
and the meaning behind the results that one could gather.
SECTION 1.3.1: MORRIS WATER MAZE AND BARNES MAZE
Two tests often utilized when determining behavioral deficits in rodent models,
which are the most utilized in TBI research, are the Morris water maze (MWM) and the

Barnes maze (BM). Both tasks aim to determine a test subject’s spatial learning and
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memory skills without a restriction to movement. Each test has similar features, such as
extra-maze visual cues facing toward the maze in the north, south, east, and west
directions. It is worth noting that these are arbitrary distinctions and not related to
compass directions. The goal of these tests is to find an escape area, particularly a hidden
platform in the MWM and an escape box in the BM, that remains static throughout each
week of training, with the start location randomized to ensure allocentric navigation.
Additionally, both tests can utilize a reversal trial where the escape area is located
opposite of its placement the week prior to test the ability to relearn spatial navigation.
Standard protocol usually has these escape areas in the southeast quadrant for the first
week and the northwest quadrant in the reversal week [35, 36].
Despite many similarities, there are also various differences between the two
maze styles. The MWM differs from the BM as it uses a negative environmental factor,
water immersion, to promote learning [35]. Water immersion causes high stress and tends
to result in an increase in corticosterone levels in plasma when compared with the BM
[37]. While this may be the biggest difference, the MWM also uses a different search
strategy analysis due to its vastly different methodology. These search strategies can
show if the animal is learning through visual cues, geometric information of the maze, or
random behaviors [38]. When quantifying search strategy data for the MWM, three
groups of strategies, each with three subgroups, are determined: spatial, non-spatial, and
repetitive looping strategies. The subgroups are as follows: for spatial strategies, there are
spatial direct, spatial indirect, and focal correct strategies; for non-spatial strategies, there
are scanning, random, and focal incorrect; for repetitive looping strategies, there are

chaining, peripheral looping, and circling. These spatial strategies can show differences
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in learning between the spatial and non-spatial groups versus the repetitive looping
groups due to the association between the hippocampus and memory of spatial landmarks
in relation to the subject’s goal [38]. In comparison, the BM has a much more simplified
search strategy analysis which consists of direct, serial, and mixed (or random) strategies
[35]. Direct strategies are defined as a direct movement toward the target hole or to the
holes adjacent to the target. Serial strategies are defined as strategies where the animal
first visits a hole non-adjacent to the target and follows in a clockwise or
counterclockwise rotation to each hole until the target is found. Mixed, or random,
strategies are defined as a series of hole searches separated by movement across the
center of the maze or a generally unorganized search. Figure 16 exemplifies each set of
search strategies using previously published examples and new search strategy examples.
Other useful data to be gathered from these tasks are the primary escape latency, where
the animal first looks inside of the target hole, and the number of primary errors, referring
to the number of times the animal attempted to escape through a non-target hole [35].
Both the MWM and BM produce a wide variety of data able to be derived from
each experiment. While all data are useful in specific contexts, certain measurements,
such as the latency to escape, path length, and cumulative distance from platform for the
MWM [36], and the primary latency, primary errors, and total path length for the BM
[35], are more useful for TBI testing, while some are just generally more useful and
highly utilized in other research contexts.

Due to the widespread use of these mazes in preclinical testing, virtual reality
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(VR) forms of multiple spatial paradigms have been created to measure cognitive deficits
in a clinical setting while remaining both ethical and practical. VR has created a unique
opportunity for clinical researchers to draw direct correlations between preclinical and
clinical testing by placing patients in a virtual environment similar to that experienced by
preclinical rodent models. The MWM VR experience has been highly explored [39];
however, no BM paradigm has yet to be created. Despite this and a lack of endogenous
stress in VR, much of the data gathered using the VR MWM may be somewhat
translational and help to connect clinical success with preclinical testing. Additionally,
VR MWM’s have shown a connection between VR testing and rodent testing through the
performance relying on hippocampal and medial temporal lobe integrity, among other
similarities [39, 40]. These two tests have shown to be incredibly useful and highly
characterized through experimentation and thus should play a major role in preclinical
research and its translation into clinical success.
SECTION 1.3.2: RADIAL ARM MAZE
The Radial arm maze (RAM) is an eight-armed, walled maze, although variations
in the specific number of arms exist. Pre-trial starvation or dehydration is used so food
and water can be used as a positive stimulus to encourage exploration (food or water
placed throughout the maze) and learning (food or water placed at the end of each arm)
[41, 42]. Spatial learning and memory are tested using extra-maze visual cues to allow
the animals to create a spatial pattern in their mind or to use nonspatial methods of
determining how to most efficiently find all the food in the maze, such as turning only
one direction. There are two major RAM paradigms: the delayed spatial win-shift and the

non-delayed random foraging. These paradigms have multiple different characteristics,
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including the former using arm blocking and two phases, while the latter uses only one
phase. Both paradigms bait half of the arms to test learning. While spatial cues are not
necessary, they are required to shift this from simply a learning paradigm to specifically a
spatial learning paradigm. For a more comprehensive look at a particular protocol,
Floresco et al. have provided a comprehensive explanation [43].
Each paradigm produces different specific datasets. The delayed paradigm data
are primarily taken from the second part of the test after the delay. At this time, errors are
counted as entries into arms that had not been previously blocked during the training
phase. Additionally, errors are split into two groups, across-phase and within-phase,
which are more thoroughly described in Table 1 [43]. The non-delayed paradigm
includes only the single trial of testing and describes errors much more broadly as any reentry into an arm, whether that arm contains bait or not. However, these are also broken
down into two subtypes: re-entries into arms that had been baited at the beginning and reentry into arms that had not been baited [43]. Both paradigms share total latency and first
latency despite their differences. While several types of data can be obtained using this,
clinical translation is often very difficult.
Similarly to the MWM, clinical researchers have used VR RAM paradigms to
attempt to connect preclinical work with clinical testing. Much like the MWM, the VR
paradigm for the RAM shows similarities to results observed in rats. For example,
clinical research has been able to demonstrate that the usage of spatial and nonspatial
learning corresponded with activation of the brain regions controlling the two forms of

learning, namely the hippocampus and caudate nucleus, respectively, which is also
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observed in rats [39].
SECTION 1.3.3: T AND Y MAZE
T and Y mazes are similar, based on the same principle of spatial learning and
memory. Both mazes function as a two-pronged maze using either positive stimuli (e.g.,
food, novel objects) [44-46] or negative stimuli (e.g., light, electrical shock and sound, a
blocked arm) [47, 48] to promote memorization of the different arms. After training, the
stimuli are removed, and animals are tested again to measure memory. Additionally,
some variations of the T maze use distal spatial cues to help promote learning and to
determine spatial learning in a similar fashion as the MWM and BM tasks [47]. One
variation utilizes both positive stimuli during training and spatial cues in a combined
system. In this variation, mice are tested for two forms of spatial learning, place learning
and response learning [39]. Place learning can be described as the utilization of spatial
cues to determine location, while response learning can be described as using internal
cues such as the direction of a particular movement. For example, the animal would be
using place learning if it turns toward the reward during the probe trial and response
learning if it turns away from the reward. Essentially, place learning and response
learning can be equated to spatial learning and nonspatial learning, respectively.
The T and Y maze offer very few data, even with the dual-solution T maze which can
distinguish between place and response learning in the rodent model [49]. The alternating
T maze, which utilizes two phases involving a training phase where one arm is blocked,
measures time spent in the unblocked, or novel, arm as a percentage of total time spent in
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the maze. While this measurement is a general measurement used in most T and Y maze
testing despite the version, the alternating T maze also uses forced alternation as a data
point [50].
The T and Y maze have a less significant clinical connection when compared to the VR
MWM or RAM. These issues stem from the simplicity of the maze, which is ironically
one of the reasons these can be such popular mazes. These mazes have the same issues
that plague others, specifically the lack of motivation in humans [39]. Humans do not
have the same motivations in VR as animal models do in preclinical testing, such as the
potential for drowning, starvation, or even minor annoyances such as the strong lighting
in the BM. Therefore, human patients require some outside source to provide a stimulus
while the test is taken in VR, such as food or monetary rewards. Regardless of other
methods to increase virtual T maze viability, the MWM and RAM VR tasks seem to
show much more promise as a viable connection between the preclinical and clinical
sides of testing.
SECTION 1.3.4: NOVEL OBJECT LOCATION TEST
In the Novel Object Location test, rodents are allowed to explore an empty open

field for 5 min. Animals are then given a 5 min trial one hour later with the objects placed
in the open field and then another 5 min trial one hour later with one object in the same
place and another object in a new place within the field [39, 51]. The one-hour inter-trial
interval forces the animal to rely on the long-term memory rather than short-term
memory or luck. Rodents are expected to use their natural curiosity to spend more time
examining the object in a novel location as opposed to the object which had not moved.
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However, deficits are shown when animals chose to explore both objects similarly to the
middle phase prior to object relocation, showing an inability to remember the familiar
location when faced with a novel location.

The Novel Object Recognition task is a nonspatial variation of the Novel Object Location
task. In this test, rather than one of the same two objects being moved to a new location,
the object is instead replaced with a new object the animal is unfamiliar with. Similarly to
the Novel Object Location task, it is expected that TBI animals will spend a near equal
time exploring both objects while uninjured animals will spend more time exploring the
novel object [51].
At this time, human equivalents are only connected to the delayed non-match to sample
task, which itself is a behavior test used with animals already [52]. This separate test is
administered by giving the subject an initial set of stimuli, generally a set of objects, and
providing a separate, novel object after a delay and requiring the subject to select the
novel stimulus [52]. The changing of objects can create a thorough connection to the
Novel Object Recognition task; however, this is considered to be more similar to the
delayed match to sample task as there seems to be some correlation between the slightly
different mechanisms of memory used in each task.
Both tasks share data similarities, as time spent with the novel object or location in terms
of a fraction of time spent in the maze are the primary data point of measurement.
However, a metric called the discrimination index is also used and measured by
subtracting the time spent exploring the familiar location or object from the time spent
with the novel location or object divided by the total time exploring either object. It is
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important to note that this does not mean the total time spent in the open field but rather
the summation of time spent exploring either object or location [53].
SECTION 1.3.5: NONSPATIAL VARIATIONS OF SPATIAL LEARNING TASKS
Many paradigms such as the RAM, MWM, and BM can test for nonspatial
learning. Indeed, in each task, there are methods with which nonspatial learning can be
examined without changing the protocol. Nonspatial search strategies can be present in

each task, such as serial exploration in the RAM and BM and MWM strategies that show
knowledge of the existence of an escape without a direct understanding of how to get
there. Such strategies include serial strategies for the BM, random, focal incorrect, and
scanning strategies for the MWM, and chaining or serial strategies in the RAM [31, 35,
54]. However, for researchers interested in limiting these to only nonspatial navigation,
several methods have been explored, with the most common being to “drown out” or
remove any extra-maze cues. Nonspatial navigation targets a different area of the brain
when compared to spatial navigation. Particularly, the area which is most considered to
dominate spatial navigation is the hippocampus, while the area most correlated with
nonspatial navigation, also thought to be heavily implicated in the same areas as spatial
navigation, implicates other brain regions such as the caudate nucleus and entorhinal
cortex [55]. While nonspatial learning is a large field within neuroscience, its reasoning is
less understood when compared to spatial learning, and therefore, it is less effective when
determining differences between injured and uninjured animals or patients

SECTION 1.3.6: FORCED SWIM TEST
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The forced swim test was designed originally for testing of antidepressant drugs
and is accepted as a preclinical model of depression because of its usage in testing for
anti-depressant medication [56]. The protocol for this test requires a 10 cm diameter
transparent cylindrical tank filled with water to 15 cm from the bottom. Both diameter
and depth can be altered to change behavior, such as the length of time mice were willing
to maintain struggle by continuing motor activity which increased with larger tank
diameter and deeper water [57]. These conclusions, while important in the field of antidepressant testing, have less importance within the field of TBI testing, where, for the
sake of the effects of TBI on depression, the standard depth and tank width provide
sufficient information to researchers. It is worthy to note that the testing performed by
Sunal et al. found that larger tanks with a longer duration, namely 15 min, may provide a
more accurate measurement without as many issues of false positives [57]. The water
should be room temperature and rodents should be placed in the tank gently and remain
there for six minutes. Intervention in the test should only be carried out if the rodents
cannot maintain swimming or floating, or, in a special case with mice, any diving
behavior is observed [56].
The data derived from these experiments have three basic components: time spent inert,
time spent climbing, and time spent struggling. While an animal is climbing, it is
attempting to come up the side of the vessel of water. While an animal is struggling, it is
making active movements to try and stay afloat or get out of the water. While an animal
is inert, it is making no movement and can thus be considered as an act of despair, similar

to depressive-like symptoms in humans. The major data point for this test is the time
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spent inert, which can be interpreted as depressive-like symptoms.
SECTION 1.3.7: OPEN FIELD TEST
The open field test is useful for measuring both locomotion and anxiety-like
behaviors in rodents and is one of the most commonly used methods of behavioral
testing, especially in rodents. The field consists of a walled area with a light focused
directly above the area with a 10 min limit to the test. For anxiety testing, measurements
of time spent in the outside area of the maze, known as thigmotaxis, are considered to be
a marker of anxiety-like behavior. The more time an animal spends in the center of the
arena, the less anxiety-like the animal’s behavior. Additionally, movement can be
measured with higher amounts of distances travelled being considered as an anxiety-like
reaction [58]. When used for motor coordination, the above-described methods are still
used, but different measurements are taken. Data for this test include distance moved,
time spent walking and running, slower or hyperactive movements, jumping, rearing, and
other rodent behaviors described previously. However, the most used and understood
data point for motor coordination is the distance travelled [58]. Depending on the timing
of this test, one should expect slower movement in TBI mice in the acute phase and more
hyperactive movements in the chronic phase, as well as a lower distance moved and
higher distance moved for TBI mice in the acute and chronic phases, respectively [59].
Along with the rotarod test, this test is highly characterized and accepted by the
behavioral testing community.

SECTION 1.3.8: RESIDENT INTRUDER TEST
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The resident intruder test is a common test for aggression. Much of the data
gathered from this test are specifically behavioral, relying heavily upon noticing
differences, frequency and duration of offensive aggression, defensive aggression, and
violence. Each of these categories have well-defined parameters as described by
Koolhaas et al. To establish territoriality with rodent models, a male is housed with a
sterilized but hormonally intact female companion for at least one week. During the test,
the female is replaced with a novel male into the cage and observed to determine a
battery of scoring measuring two opposites of behavior, aggression and
sociability/anxiety, measured by the Total Offense Score and the Social Exploration
Score, respectively [60]. Additionally, latency to first attack is also an often-used
measurement to determine aggression with lower latency corresponding to a higher
amount of aggression. This protocol can also be adjusted for female mice with almost no
change, except to make sure female companions are age-matched to avoid conflict [61].
SECTION 1.3.9: ROTAROD
The rotarod test is a widely used test to determine coordination deficits in rodents.
A linearly accelerating cylinder that animals are placed on continues to rotate until all
animals have fallen or until the final time point is reached. This is most effective for
motor deficits in the acute phase of injury, but may also be used later prior to cognitive
testing to ensure there are no motor deficits when using methods such as the MWM,
RAM, or other spatial or nonspatial learning tasks. Latency to fall is the most important
measurement with this method; however, qualitative analyses can include coordination
by way of the method with which the animal stays on the rotarod [19, 59].

SECTION 1.3.10: FOOTPRINT PATTERN ASSAY
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The footprint pattern assay is executed by dipping a rodent’s paws in different ink
colors for the fore and hind paws and leading them down a tunnel lined with paper.
Through this method, abnormalities in gait and coordination can be observed.
Additionally, many parameters are capable of being measured, such as stride distance,
stride length, variability across the center axis of the paper, width between hind paws,
step regularity, and step overlap. Many of the most important aspects of the footprint
assay include the step length, step duration, and inter-leg coordination, as described in
Table 1 [62]. Modernized versions of this assay are automated and also capable of
measuring pressure and speed, such as the CatWalkTM system [63-65].
SECTION 1.3.11: DESCRIPTION OF RESEARCH
In this work, I used two different spatial learning and memory paradigms
designed to indirectly measure the spread of secondary injury. The rationale for this is
that the right hippocampus has been shown to be the dominant side relating to spatial and
learning memory in both humans and mice [66, 67]. Using a CCI model with mice, an
impact is applied to the left cortex through a craniotomy. After 3 weeks, the spatial
learning and memory tasks are given to measure how nanoparticle treatment in the acute
phase can affect deficits in learning and memory during the chronic phase of injury. My
goal was to identify and develop a paradigm and protocol that generates large differences
between uninjured control mice and CCI mice so that various NP-based treatments can be
assessed and compared.

CHAPTER 2: MORRIS WATER MAZE
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Experiments involving the MWM were done in collaboration with Ali Manske
and Dr. Sarah Romereim to test the efficacy of an antioxidant NP treatment on TBI. The
MWM was chosen over other paradigms as it is highly characterized in literature and is
the most used behavioral test for cognitive deficits [68]. Additionally, mice were tested
using Rotarod to determine motor coordination prior to MWM testing.
SECTION 2.1: METHODOLOGY
The antioxidant NPs used in this study were previously reported by Yoo, et al.
and are called NP1 [30]. These NPs utilize a thioether bond to scavenge reactive oxygen
species (ROS), a cause of oxidative stress and a major contributor to the secondary injury
cycle. A volume of 100 µL at a concentration of 1 mg/mL was injected intravenously
through tail vein injection immediately following TBI for each NP treated mouse.
From my previously published literature [69]:
SECTION 2.1.1: CONTROLLED CORTICAL IMPACT SURGERIES
All animal procedures were performed in accordance with the approval of the
University of Nebraska−Lincoln IACUC. Six-week-old male and female C57BL/6J mice
(Jackson Laboratory, Bar Harbor, ME, USA) were acclimated for 2 weeks prior to the
procedures. Mice were anesthetized with 3% isoflurane gas via inhalation and were
maintained at ∼1.5% with a nose cone on a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA). The hair of the scalp was removed with Nair (Church and Dwight

Co., Inc., Princeton, NJ, USA), and the scalp was disinfected with a betadine scrub and
isopropanol wipes afterward. Lidocaine (0.05 mL of 5 mg/mL) and bupivacaine (0.05 mL

of 0.3 mg/mL) were applied to the scalp, and buprenorphine SR (60 µL of 0.5 mg/mL)
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was given subcutaneously. An approximately 1 cm midline incision was made on the
scalp over bregma. An approximately 2 mm craniectomy was made in the skull over the
left frontoparietal cortex (2 mm anterior and 2 mm left of lambda) using a surgical drill.
A controlled cortical impactor (Hatteras Instruments, Cary, NC, USA) attached to the
stereotaxic frame with a 2 mm convex tip was used to impact the brain normal to the dura
surface at a depth of 1.5 mm and a velocity of 4 m/s with a dwell time of 80 ms. Any
bleeding was controlled and incisions were closed using tissue adhesive. NP1 (100 μL of
1 mg/mL) was injected through the tail vein immediately after the surgery for the NP1
treated group. With the average weight of 22.24 g for male mice and 16.44 g for female
mice, the average dose of NP1 administration was 4.5 mg/kg for male mice and 6.1
mg/kg for female mice. The size of each treatment group is as follows: 15 mice in the
control group, 21 mice in the untreated CCI group, and 13 mice in the NP1 treated CCI
group. This includes both male (8 CCI, 5 NP1, 5 control) and female (13 CCI, 8 NP1, 10
control) in three separate MWM experiments with two experiments consisting of female
mice and one of male mice.
SECTION 2.1.2: ROTAROD
A Rotor-RodTM motor function system (San Diego Instruments, San Diego, CA,
USA) was utilized to assess the motor function and learning of the mice prior to all
MWM studies. Rotarod trials were started 3 days post-CCI and were repeated daily for 5
days. Mice were placed onto the cylinders, which then began to rotate. The speed linearly
increased from 0 to 50 rpm over 5 min. Latency to fall was averaged over 5 separate runs
for each animal each day.

SECTION 2.1.3: MORRIS WATER MAZE
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The MWM behavior analysis was executed based on a previously published
protocol about assessing spatial learning and memory [36]. The MWM experiment was
started 3 weeks post-CCI and consisted of two trials: spatial acquisition and reversal. The
mice were trained to find the platform using a visible marker before covering the
platform with opaque water (white tempura paint) and removing the platform marker.
The platform was placed in the southwest quadrant during acquisition trials with the mice
starting randomly in the north, east, southeast, and northwest quadrants. The platform
was moved to the northeast quadrant during reversal trials with the mice starting
randomly in the south, west, northwest, and southeast quadrants. Spatial cues were placed
in the north, south, east, and west directions as extra-maze cues. In both acquisition and
reversal trials, the mice underwent four trials per day for four days. Male mice (18 total, 8
CCI, 5 NP1, 5 control) and female mice (31 total, 13 CCI, 8 NP1, 10 control) were
employed for the MWM trial. Testing for each sex was done separately from each other.
Search strategy analysis was done by two researchers separately then results were
combined and analyzed as a group. Results were recorded and data analyzed in GraphPad
PRISM 7 (GraphPad Software, CA) using the percentages of each experimental group’s
usage of each spatial strategy.
SECTION 2.1.4: STATISTICAL ANALYSIS
All the data in this study were expressed as mean ± standard error of the mean
(SEM). A p < 0.05 was considered statistically significant. For latency to escape, KaplanMeier survival analysis with Mantel-Cox log-rank test was employed to account for the
non-normal distribution of latencies resulting from the 90 second maximum trial duration.
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Other data were evaluated using a two-way analysis of variance (ANOVA) with Tukey’s
multiple comparisons test and one-way ANOVA for the probe trials. All statistics were
analyzed with GraphPad Prism 7 software (GraphPad Software, CA).
SECTION 2.2: RESULTS

Figure 2.1. Motor coordination results before and during the MWM.
As shown in Fig. 2.1, no significant motor deficits were found during the Rotarod
testing in the subacute phase 4 to 8 days post-TBI and were confirmed during both the
spatial acquisition and reversal weeks of the MWM using swim speed as a metric for
motor coordination. In Fig. 2.2A, only two days were showed statistically significant
differences between the control and CCI groups were day 3 of the spatial acquisition
week and day 1 of the reversal week. Additionally, significant differences between the
CCI and NP1 treated groups on days 3 and 4 of the spatial acquisition week and days 1
and 3 of the reversal week. Other differences during the acquisition and reversal weeks
are shown in Fig. 2.2C where significant differences between the CCI and both the
control and NP1 treated groups were found when averaging full week of trials for the
fraction of time spent in the outer annulus. While statistically significant differences were
noticed during each week of training, the probe trial day showed very little significance
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as seen2.2.
in both
Fig. 2.2B and
Fig. 2.2D.
The
in any
of the
Figure
A) Percentage
of escape
based
offonly
totalsignificant
latency to difference
escape using
Kaplan-Meier
regression. B) Probe trial latency to first visit to former target area. C) Fraction of time
spent in the outer annulus. D) Probe trial fraction of time spent in the outer annulus. E)
Percentages of each search strategy used during the acquisition and reversal weeks. * =
p<0.05, ** = p<0.01, *** = p<0.001 between control and CCI groups, # = p<0.05, ## =
p<0.01, ### = p<0.001 between CCI and NP1 treated groups.

probe trial parameters was shown between the CCI and NP1 treated groups on the
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acquisition probe trial in the fraction of time spent in the outer annulus. There was no
significant difference seen between the control and CCI groups in that same probe trial.
Additionally, the control and NP1 treated groups began utilizing the spatial search
strategy, a sign of increased spatial learning and memory, more than 50% of the time on
day 2 of the acquisition week while the CCI group lagged behind and were inconsistent
throughout the week, as seen in Fig 2.2E. When the total amount of search strategies are
averaged across the spatial acquisition and reversal weeks, control and NP1 treated mice
used the spatial search strategy 56.3% and 54.9% of the time, respectively. Meanwhile,
CCI mice only used the spatial search strategy 45% of the time, significantly less than
both groups (p<0.05). When broken down specific to sex, statistically significant
differences were even more sparse regarding total latency in both the female and male
mice. In Fig. 2.3A, it is shown that the only significant difference between the control
and CCI female mice was on day 4 of the spatial acquisition week. Significant
differences were seen between NP1 treated female mice and their CCI counterparts on
days 1 and 3 of the reversal week. When considering the probe trial statistics (Fig. 2.3B
and D) female mice had no statistically significant differences in either probe trial latency
or fraction of time spent in the outer annulus. However, it is worth noting that the mean
fraction of time spent in the outer annulus by the CCI group is nearly twice that of the
control and NP1 groups in both the acquisition and reversal probe trials. Significant
differences in the weekly average of time spent in the outer annulus were found between
the CCI and controls in both weeks with the female mice (Fig. 2.3C) and only in the
reversal week with male mice (Fig. 2.3G). For the male mice, significant differences in

escape percentage were found on between CCI and control mice on days 1 and 3 of the
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acquisition week and days 1 and 2 of the reversal week (Fig. 2.3E). When it comes to
probe trial measurements, male control mice performed significantly worse than CCI
mice in the probe trial latency (Fig. 2.3F), however the mean probe trial fraction of time
spent in the outer annulus (Fig. 2.3H), while not being statistically significant, shows a
nearly 2-fold difference between the CCI and control groups, similarly to female mice.
This does not continue for the reversal week. In fact, male CCI mice in the reversal week
showed significant differences in fraction of time spent in the outer annulus on average
across the week when compared to control mice as shown in Fig. 2.3G. Search strategy
analysis revealed some interesting trends when broken down by sex. During the
acquisition week, control male mice showed a slightly higher percentage of spatial
strategies used at 62.5% compared to their female counterparts who utilized spatial
strategies 58.4% of the time. Additionally, the comparisons for the CCI group show male
mice utilizing spatial strategies only 38.3% of the time while female mice used spatial
strategies 51.1% of the time. While both percentages are lower than the amount used by
the control groups at this time, the large difference between male and female mice
regarding the effect of injury on spatial learning is worth note. Another interesting aspect
of the search strategy results is within the reversal week. When combined, the control
group slightly edges out the CCI group in spatial strategies used at 44.8% and 40.3%,
respectively. However, when separated by sex, the control males come in at 46.8% and
CCI males at 50.3%, showing that male CCI mice seemed to use more spatial search
strategies than control. This is countered by the looping strategy comparison, where CCI
male mice used those strategies 9.4% of the time compared to 1.3% for controls. Female
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Figure 2.3 A) Percent escaped for spatial acquisition and reversal trials, female mice. B)
Probe trial latency to first visit to target, female mice. C) Fraction of time spent in the
outer annulus, female mice. D) Probe trial fraction of time spent in the outer annulus,
female mice. E) Percent escaped for spatial acquisition and reversal trials, male mice. F)
Probe trial latency to first visit to target, male mice. G) Fraction of time spent in the outer
annulus, male mice. H) Probe trial fraction of time spent in the outer annulus, male mice.
I) Search strategies examples used in the MWM. J) Percentage of each search strategy
used separated by week and sex.

mice, however, showed a significant decline across the board for spatial strategies with
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43.8% for controls and 33.5% for CCI and the opposite situation for looping strategies
with controls and CCI groups using this strategy 6.3% and 5.9% of the time, respectively.
SECTION 2.3: DISCUSSION
While our MWM data showed promising results, the separation between control
animals and CCI animals were not large enough to show many significant differences on
either week combined or within either sex. Search strategies and fraction of time spent in
the outer annulus proved to be the most effective methods in measuring spatial learning
and memory deficits in the combined statistics and male mouse groups. This is useful for
assessing NP efficacy; however, the fraction of time spent in the outer annulus can also
be connected to search strategy analysis as a peripheral looping strategy, one of the three
looping strategies most often associated with spatial deficits, often result in animals
spending an excess amount of time in the outer annulus. These looping strategies were
also shown to be higher in CCI mice in the male, female, and combined groups on both
weeks, with some notable exceptions in the spatial acquisition week for males and the
reversal week for females. While this may suggest a difference in cognitive flexibility,
the lack of probe trial differences and separation between control and CCI mice in total
latency seem to instead suggest that there was an issue with the MWM resulting in
suboptimal results. When looking at the escape percentages, very little difference was
observed in both the sex-separated data and combined data. Despite being a measurement
of the training weeks, this lack of separation is especially concerning considering the lack
of differences in the acquisition and reversal probes, indicating learning within each
group is much less than what is needed for effective testing. When focusing on the

separated sex data, it seems that there is a more noticeable gap in total latency between
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control and CCI groups within the male mice. This was an expected result as male mice
have been noted to be outperformed by female mice when both have undergone CCI [70].
SECTION 2.4: CONCLUSIONS
NP1 had some effect when averaging the whole of the groups; however, the lack
of probe trial differences between control and CCI mice weaken our ability to claim NP1
efficacy. The MWM showed minimal separation between injured and uninjured animals
except on day 3 of the spatial acquisition week and day 1 of the reversal week for the
combined data. However, these findings allowed us to determine a moderate
neuroprotective role of NP1 when in tandem with various molecular and histological
correlates that showed significant differences between CCI and control groups (not part
of this thesis), even despite the mild-to-moderate injury model used. Most importantly,
this work allowed us to identify two potential opportunities for improvement in our
behavioral testing. One involves increasing CCI injury severity, which could aid in
creating greater differences between control and CCI groups. Secondly, a separate
paradigm with less endogenous anxiety, more time for exploration, and more data to
describe how the mice are learning could help improve performance of control mice and
increase observable differences from CCI mice.

CHAPTER 3: BARNES MAZE OPTIMIZATION
We chose the BM to test spatial learning and memory without the anxiety created by
placement in water as with the MWM. Male mice were the original focus of these tests as
they have been known to perform worse than their female counterparts post-TBI and are

expected to perform better than female mice when healthy, as has been reported in both
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rats and humans [71, 72]. In mice, repetitive concussive TBI has shown lower
impairments chronically than males, however CCI models have shown mixed results
regarding cognitive deficits [70, 73]. Additionally, previous work into spatial learning
and memory as it pertains to TBI showed males with slightly more pronounced deficits.
While MWM data on these differences has been mixed in mice, BM reports suggest that
these differences exist, whether that be from sex hormone or a sex-dependent effect on
injury or anesthetic [70]. This study focused on determining the most efficient method for
expanding deficits between CCI and control groups while being able to ensure learning in
both groups.
SECTION 3.1: METHODOLOGY
SECTION 3.1.1: TRADITIONAL BARNES MAZE
One protocol we used was a standard and widely accepted protocol adapted from
Gawel, et al. 2019 [35]. This protocol consisted of 2 weeks with 5 days of spatial
acquisition trials in week 1 and 5 days of reversal trials in week 2 with one probe trial on
day 6 of each week. Training trials were 180 seconds with 2 trials per day and a 30
second period either after escape or at the end of the 180 seconds for the mice to stay in
the escape hole with the top covered. At the end of each training trial, if the mouse had
not escaped, the mouse was placed in the escape. For each probe trial, the escape box was
removed and the mice were allowed to explore the maze for 90 seconds. In both the

training and probe trials phases, four spatial cues were placed and labeled as the north,
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south, east, and west (Figure 3.1).

Figure 3.1 An image of the Barnes Maze that was used in these experiments with one of
the two 50 W bulbs and two of the four spatial cues showing.
One day prior to the spatial acquisition week, the mice were allowed to explore the maze
for 60 seconds with the spatial cues hidden and both 50 W lightbulbs on and directed
toward the maze. After these 60 seconds, the mouse was led to and placed in the escape
box for 120 seconds with the escape hole covered. After each trial, the maze and escape
box were cleaned with 70% ethanol and wiped clean before the next trial began. All
testing took place on a 93 cm diameter platform with 20 holes placed evenly around the
platform, just inside the diameter an equal distance from the edge (Noldus Information

Technologies, Leesburg, VA, USA). Videos of each trial were acquired with a 1080p
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high-definition camera then converted into mp4 format and analyzed using EthoVision
XT (Noldus Information Technologies, Leesburg, VA, USA).
SECTION 3.1.2: UPDATED BARNES MAZE
We designed a new, shortened BM that used the same platform, lights, spatial
cues, cleaning, and data acquisition process and software. Based on our finding from the
traditional BM protocol, we altered the number of trials per day, length of the acquisition
week, and purpose of the probe trials. Additionally, removing the reversal week allowed
for a more focused approach on measuring short-term and long-term memory as opposed
to the standard cognitive flexibility measurements gained from the reversal week. This
updated BM is comprised of one spatial acquisition week lasting 6 days with three 180
second trials per day. Like the former protocol, if the mouse did not escape in 180
seconds, it was then led to and placed in the escape hole. However, in this protocol the
mouse was led to the escape using a clear 2-liter beaker and allowed to enter the escape
hole on their own. The probe trials took place on days 7 and 10 as a potential method of
measuring short-term and long-term memory. Each probe trial lasted 90 seconds with the
escape removed in the same manner as the old protocol. Further differences lie in the pretraining trial (day 0) where instead of the spatial cues being hidden, they were visible to
the animal from the platform. Additionally, after the first 60 seconds to explore the maze,
the mouse was then led to the escape hole using a 2-liter beaker and allowed to enter the
escape on their own before the hole was covered and mice are given 120 seconds in the
escape hole.

SECTION 3.1.3: CONTROLLED CORTICAL IMPACT
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All animal procedures were performed in accordance with the approval of the
University of Nebraska−Lincoln IACUC. Seven-week-old male C57BL/6J mice (Jackson
Laboratory, Bar Harbor, ME, USA) were acclimated for 1 week prior to the procedures.
Mice were anesthetized with 3% isoflurane gas via inhalation and were maintained at
∼1.5% with a nose cone on a stereotaxic frame (David Kopf Instruments, Tujunga, CA,
USA). The hair of the scalp was removed with Nair (Church and Dwight Co., Inc.,

Princeton, NJ, USA), and the scalp was disinfected with a betadine scrub and isopropanol
wipes afterward. Lidocaine (0.05 mL of 5 mg/mL) and bupivacaine (0.05 mL of 0.3
mg/mL) were applied to the scalp, and buprenorphine SR (60 µL of 0.5 mg/mL) was
given subcutaneously. An approximately 1 cm midline incision was made on the scalp
over bregma. An approximately 2 mm craniectomy was made in the skull over the left
frontoparietal cortex (2 mm anterior and 2 mm left of lambda) using a surgical drill. A
controlled cortical impactor (Hatteras Instruments, Cary, NC, USA) attached to the
stereotaxic frame with a 2 mm convex tip was used to impact the brain normal to the dura
surface at a depth of 2.5 mm and a velocity of 4 m/s with a dwell time of 80 ms. Any
bleeding was controlled and incisions were closed using tissue adhesive. The size of each
treatment group is as follows: 10 mice in the old protocol control group, 10 mice in the
old protocol CCI group, 10 mice in the new protocol control group, and 7 mice in the
new protocol CCI group. The control experiments were done in groups of 5 mice
separated into different weeks while the CCI groups were done in tandem with a group of
5 NP treated mice. This latter group will be discussed further in Chapter 4.

SECTION 3.1.4: STATISTICAL ANALYSIS
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All the data in this study were expressed as mean ± standard error of the mean
(SEM). A p < 0.05 was considered statistically significant. Escape frequency using total
latency was analyzed using Kaplan-Meier survival analysis with a Mantel-Cox log rank
test. Weekly training statistics were analyzed using two-way ANOVA or a mixed-effects
model when applicable. Probe trial data was analyzed using an unpaired t test with
Welch’s correction. All data analyses were performed using GraphPad Prism 9
(GraphPad Software, CA).
SECTION 3.2: RESULTS
Fig 3.2A shows the full week of escape frequency by total latency throughout
using the new protocol. An increase in escape frequency across the six days of the
updated BM was observed. On day 1, 10% of control mice escaped within 143 seconds.
On day 2, there was a decrease in escape frequency and increase in latency for control
mice with only 3.3% of mice escaping before 172.9 seconds. On day 3, 10.1% of control
mice escaped before 98 seconds while nearly 21% escaped prior to 172.8 seconds. CCI
mice performed the same on days 1, 2, and 3 with zero escapes in the 180 seconds given.
On day 4, CCI mice were able to escape 4.76% of the time prior to 159.3 seconds,
however there were no further escapes. Control mice on the same day, however,
surpassed a 50% escape frequency by 179.3 seconds with 51.87% escaping prior to that
point. Notably, 33.333% of control mice had escaped prior to 113.3 seconds. On day 5,
these differences continued to expand with CCI mice showing a 28.57% escape at 166.6
seconds and control mice escaping at 73.333% by 142 seconds. Additionally, control
mice reached a 50% escape frequency at 60.8 seconds. On day 6, control mice reached

50% escape at 15.3 seconds and reached a peak escape frequency of 76.667% at 111.6
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seconds. CCI mice reached a peak escape frequency of 38.1% at 141.8 seconds.
Statistically significant differences were noticed on days 3, 4, 5 and 6 between the control
and CCI groups when using the updated BM protocol.
In Fig 3.2B, the same data as discussed in the last paragraph is reported for the
traditional protocol. Day 1 had a peak escape frequency of 36.8% and 25.3% at 169.8 and
180 seconds for the control and CCI groups, respectively. Day 2 showed a decrease in the
frequency as well as a decrease in total latency for both control and CCI groups. Control

Figure 3.2 Comparison in escape frequencies by day between the traditional and updated
Barnes Maze protocols. A) Traditional protocol escape percentages for the spatial
acquisition week. B) Updated protocol escape percentages for the spatial acquisition
week. * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001
mice had an escape frequency of 15% before 153.7 second and CCI mice had a frequency
of 10.5% before 176 seconds. Day 3 also showed a decrease in escape frequency and
latency but only for the CCI group with an escape frequency of 6.667% at a time of 169.7

seconds. Control mice had 20% of the group escape before a time of 165.4 seconds. On

38

day 4, the escape frequencies were statistically significantly different with control mice
escaping 40% of the time before 149.7 seconds and CCI mice escaping only 10% of the
time by 174.4 seconds in the maze. Finally, on day 5, significant differences were again
seen, and control mice reached a 50% escape frequency at 136.2 seconds. CCI mice,
however, highly underperformed and had zero escapes throughout the full 180 seconds.

Figure 3.3 A) Primary error comparison of both protocols control (left) and CCI (right)
groups. B) Primary latency comparison of both control (left) and CCI (right) groups. C)
Total errors comparison of both protocols control (left) and CCI (right) groups. D)
Returns to goal comparison of both protocols control (left) and CCI (right) groups.
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The primary errors between control and CCI groups were compared to determine
the effect the updated protocol had on spatial learning (Fig. 3.3A). For the sake of this
comparison, the acquisition probe from the traditional protocol is compared to the shortterm memory probe from the updated protocol. For control mice, the updated protocol
showed significant differences on days 2 and 4 of the acquisition comparison compared
to the traditional protocol as well as a significant difference in the probe trial day. CCI

Figure 3.4 Control and CCI group protocol trial by trial comparisons. A) Total latency by
trial B) Total errors by trial C) Primary errors by trial D) Primary latency by trial E)
Returns to goal by trial F) Distance travelled by trial.

mice, however, showed no differences but showed high variability independent of the
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protocol used and a lower mean in the probe trial when going through the updated
protocol. Similarly, primary latency showed significant differences between the control
groups in the probe trial while the CCI mean was also lower using the updated protocol.
During the week, CCI animals again showed high variability and no notable differences
while the controls groups are significantly different on day 2 as seen in Fig. 3.3B. When
looking at the differences between total errors in Fig. 3.3C, no observable changes
regarding the probe trials, however the mean value of total errors between the protocols
in the CCI group is lower in the updated protocol on days 4 and 5 than in the traditional
protocol. This also is shown in the control groups where the total errors are significantly
different on days 4 and 5 with the updated protocol seeing decreased errors.
Alternatively, returns to goal showed no significant differences during the week in
both the control and CCI group comparisons, however the probe trial control comparison
showed significant differences between the traditional and updated protocols (Fig 3.3D).
The CCI comparison, while not statistically significant, was trending toward better
performance in returns to goal during probe trial for the updated protocol when compared
to the traditional protocol.
With significant differences were seen between the traditional BM protocol when
compared to the updated protocol, we wanted to identify whether these differences were
based off increased learning due to additional trials or an increased learning within the
same number of trials. When comparing trial-by-trial rather than day-by-day, both
protocols seemed to follow the same trend regardless of treatment. The high variability

within each trial made it difficult to notice any major differences; however, some
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noteworthy comparisons were seen in the total latency (Fig. 3.4A), primary errors (Fig.
3.4C), and returns to goal (Fig 3.4E). While total latency for the CCI comparison was
relatively the same except for an initial better start for the traditional protocol, it seems
that the tenth trial between the controls of each protocol showed a lower mean latency for
the traditional protocol. However, after further trials, the updated protocol surpasses the
best total latency the traditional protocol was able to obtain. When looking at primary
errors, the traditional protocol control means had much less of a continuous decrease
when compared to the updated protocol control. Returns to goal also had some notable
control comparisons with the traditional protocol means being much lower than the
updated protocol means in trials 8, 9, and 10.
SECTION 3.3 DISCUSSION
Firstly, with little differences shown and no significant differences in the trial
comparisons, there is reasonable evidence that the updated protocol provided no
difference to increasing learning and memory in the BM on a trial-by-trial basis. This
ultimately leads to the conclusion that the differences seen in Fig 3.1 and Fig. 3.2 are
based upon the increased volume of trials per day and the addition of a 6th day. The
addition of this day increased learning dramatically and allowed for a wider gap for
measuring deficits between the control and CCI groups both during the week and in the
probe trials. A major focus of this section has been the protocol differences. While the
data showed a growing gap between the control groups of each protocol, the CCI groups
stayed relatively similar in much of the data. This indicates an increased separation
between the control and CCI groups within the updated protocol. Much of the CCI data
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shows similarities between the updated protocol and traditional protocol with most of the
major differences occurring in escape frequency. When looking at the escape frequency
data of the traditional protocol, the data showed that both the control and CCI groups
started with higher percentages of escape and total latencies and ultimately bottomed out

on day 3, apart from the CCI group which showed its lowest values on day 5. The lack of
escapes on day 5 for the CCI group compared to the nearly 30% escape on day 5 for the
updated protocol itself exemplifies the increased ability of the updated protocol on spatial
learning. Indeed, the whole of the escape frequency data gives strength to the validity of
the updated BM protocol between the steadily increasing escape frequencies for both the
control and CCI groups, larger gap in final day escape percentage, and four days of
significant differences. While the training days offer a great insight into how the two
different protocols compare, the ultimate test is in the probe trials. According to O’Leary
and Brown, primary errors and primary latency are critical data [35]. Due to this
importance, the significant differences in primary errors and primary latency between the
traditional and updated protocol controls is essential in confirming the validity of the
updated protocol. An additional benefit is the lower means in both primary latency and
primary errors of the CCI group comparison, adding more evidence that even the injured
animals have showed increased learning. More support for this new protocol is shown in
the significantly different total errors between each protocol controls during the
acquisition week and the significant difference between the returns to goal probe trial
between the controls in each protocol.

SECTION 3.4: CONCLUSIONS

43

The increased learning visible in the various provided data for both the control
and CCI groups in the updated protocol provides strength to the argument that this novel
updated BM protocol is capable of more precisely measuring TBI-based deficits than the
traditional BM protocol. While there is no difference on a trial-by-trial basis, the
increased number of trials over a similarly long period of time with additional day of
training led to stronger spatial learning and memory. While removing the reversal week
removes testing for cognitive flexibility, in the realm of TBI work short-term and longterm memory are a more useful metric for preclinical testing as the focus on memory and
memory consolidation shows a clearer target than separating results between two
different abilities of the brain. Thus, this novel BM protocol will allow us to provide
more powerful testing of TBI therapeutics.

CHAPTER 4: ASSESSING NANOPARTICLE TREATMENT USING
BARNES MAZE
With a novel BM protocol capable of showing significant deficits in both the
training week and probe trials between control and CCI mice, we utilized this paradigm
for the testing of TBI therapeutics. For this, an antioxidant NP similar to the one used in
the MWM study was applied to a group of animals that had undergone CCI surgery [29].
SECTION 4.1: METHODOLOGY
The BM protocol utilized is described above in Section 3.1.2 with all aspects
remaining the same as they did for prior protocol comparison testing.

SECTION 4.1.1: NANOPARTICLE DESCRIPTION
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The NP used has been previously described [29]. For use in this study, the NP
treatment, labelled as LIPOMA, was injected at a concentration of 2 mg/mL and a
volume of 100 µL immediately post CCI. This NP is similar in nature to the previously
discussed NP1, however where NP1 was specifically an ROS scavenger, LIPOMA serves
a dual purpose in both ROS scavenging and the neutralization of lipid peroxidation
products (LPOx).
SECTION 4.1.2: CONTROLLED CORTICAL IMPACT
All animal procedures were performed in accordance with the approval of the
University of Nebraska−Lincoln IACUC. Seven-week-old male C57BL/6J mice (Jackson
Laboratory, Bar Harbor, ME, USA) were acclimated for 1 week prior to the procedures.
Mice were anesthetized with 3% isoflurane gas via inhalation and were maintained at
∼1.5% with a nose cone on a stereotaxic frame (David Kopf Instruments, Tujunga, CA,
USA). The hair of the scalp was removed with Nair (Church and Dwight Co., Inc.,

Princeton, NJ, USA), and the scalp was disinfected with a betadine scrub and isopropanol
wipes afterward. Lidocaine (0.05 mL of 5 mg/mL) and bupivacaine (0.05 mL of 0.3
mg/mL) were applied to the scalp, and buprenorphine SR (60 µL of 0.5 mg/mL) was
given subcutaneously. An approximately 1 cm midline incision was made on the scalp
over bregma. An approximately 2 mm craniectomy was made in the skull over the left
frontoparietal cortex (2 mm anterior and 2 mm left of lambda) using a surgical drill. A
controlled cortical impactor (Hatteras Instruments, Cary, NC, USA) attached to the
stereotaxic frame with a 2 mm convex tip was used to impact the brain normal to the dura
surface at a depth of 2.5 mm and a velocity of 4 m/s with a dwell time of 80 ms. Any
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bleeding was controlled and incisions were closed using tissue adhesive. The size of each
treatment group is as follows: 10 mice in the control group, 7 mice in the CCI group, and
8 in the LIPOMA treated group. The control experiments were done in groups of 5 mice
separated into different weeks while the CCI groups were done in tandem with LIPOMA
treated mice.
SECTION 4.1.3: STATISITCAL ANALYSIS
All the data in this study were expressed as mean ± standard error of the mean
(SEM). A p < 0.05 was considered statistically significant. Escape frequency using total
latency was analyzed using Kaplan-Meier survival analysis with a Mantel-Cox log rank

test. Weekly training and probe trial statistics were analyzed using two-way ANOVA or a
mixed-effects model when applicable. All data analyses were done using GraphPad Prism
9 (GraphPad Software, CA).
SECTION 4.2: RESULTS
Figure 4.1A shows the distance travelled in centimeters between all groups of
throughout the training week. While significant differences were noticed between the
control group and both the LIPOMA and CCI groups across the week, the greater
distance travelled is on the part of the CCI and LIPOMA groups. Concern could be taken
for motor coordination deficits if the opposite had been true as a decrease distance
travelled in tandem with decreased velocity could mean that injured animals experienced
long-term motor impairment and are thus compensating by travelling less distance.
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Figure 4.1 A) Training week distance travelled in centimeters B) Training week velocity
in centimeters per second C) Probe trial distance travelled in centimeters D) Probe trial
velocity in centimeters per second. * = p < 0.05, ** = p < 0.01 for control vs CCI
comparisons
Additionally, to confirm the lack of motor coordination deficits, we analyzed both
distance travelled and overall velocity among the groups. Fig. 4.1B confirms that velocity
was not significantly different between all groups. Both distance travelled and velocity
showed no significant differences during the probe trial days as well; therefore, motor
coordination deficits at any point during the behavioral testing can be ruled out for any
other deficits we observed.

In Figure 4.2A, days 3 through 6 show statistically significant differences
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between the control and CCI groups with day 3 also showing significant differences

Figure 4.2 A) Escape percentages for the 6 training days. B) Returns to goal across the
training week. C) Returns to goal in the probe trials. * = p < 0.05, ** = p < 0.01, *** = p
< 0.001 for control vs CCI comparisons, # = p < 0.05, ## = p < 0.01, ### = p < 0.001 for
LIPOMA vs CCI comparisons.

between the LIPOMA and CCI groups. Going further into these results, peak escape
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frequencies on day 1 occur at 10% and 7.7% at 143 seconds and 180 seconds for the
control and LIPOMA groups, respectively. On day 2, the control group peaks at 3.333%
before 172.9 seconds while the LIPOMA group peaks at 11.111% before 147.7 seconds.
Day 3 again showed results for the control and LIPOMA groups with peak escape
percentages of 20.8% and 11.5% at 172.8 seconds and 170.3 seconds, respectively. On
the 4th day, the CCI group had its first escapes with a 4.76% escape percentage at
159.326 seconds. The control and LIPOMA groups had peak escape percentages of
47.1% at 176.4 seconds and 43.7% at 171.8 seconds, respectively. Day 5 resulted in
higher escape percentages across the board with 73.333% of control animals escaping at
or before 142 seconds, 28.571% of CCI animals escaping at or before 166.6 seconds, and
46.187% of LIPOMA animals escaping at or before 138.87 seconds. Finally, on day 6,
the escape percentages of 76.667%, 38.095%, and 60.381% for the control, CCI, and
LIPOMA groups at the latencies of 111.6 seconds, 141.8 seconds, and 150.9 seconds,
respectively. While examining the returns to goal, day 3 shows a significant difference
between the control group at a mean of 2.233 returns and the CCI group at a mean of
1.333 returns. LIPOMA mice had a mean of 1.519, however this was not statistically
significant when compared to either the control group or the CCI group. With the probe
trial, while the day 10, or long-term, probe trial did not elicit any statistically significant
results, the day 7, or short-term, probe showed significant differences between the control
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group with a mean of 3.7 returns and both the CCI and LIPOMA groups with a mean of 1
return and 2 returns, respectively.
Primary latency is shown in Fig. 4.3A. Statistically significant differences were
noticed between the control and CCI groups on days 4, 5, and 6. Additionally, as shown
in Fig. 4.3B, there are statistically significant differences between the control and CCI
groups on days 2, 3, 5, and 6. Looking at the probe trial data, no significant differences

Figure 4.3 A) Training week primary latency in seconds B) Training week primary errors
C) Probe trial primary latency in seconds D) Probe trial velocity in centimeters per
second. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001 for control vs
CCI comparisons
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are seen in both the primary latency and primary errors between any group. However, the
mean control probe trial primary latency for day 7 is 6.633 seconds and for day 10 is
8.405 seconds while the same primary latencies for the same days for the CCI group are
25.48 seconds for each day and for LIPOMA are 30.09 seconds and 34.67 seconds,
respectively. Similarly, primary errors also have large differences in the same vein as
primary latencies. Day 7 showed 1.3, 4.143, and 3.667 errors for the control, CCI, and

Figure 4.4 A) Training week total errors B) Training week exploratory errors C) Probe
trial total errors D) Probe trial exploratory errors. * = p < 0.05, ** = p < 0.01, *** = p <
0.001, **** = p < 0.0001 for control vs CCI comparisons
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LIPOMA groups, respectively, while day 10 showed 2.1, 2.857, and 5.333 errors for the
control, CCI, and LIPOMA groups.

Figure 4.4 outlines total errors and exploratory errors to assess the amount of total
exploration and exploration after the first visit to the escape. We define exploratory errors
as the difference between total errors and primary errors. This metric is mainly used to
measure the number of errors made after the first visit to the escape, and thus the number
of errors caused purely from exploration and not from active searching. While there were
no significant differences in exploratory errors, on day 6, both control and LIPOMA
animals had a mean of approximately 5 errors compared to the mean of 10 for the CCI
animals. For total errors, significant differences were noticed between the CCI and
control groups on days 2, 3, 5, and 6. While this should bode well for the probe trials, no
significant differences were noticed in either probe trial for total errors. The result of the
exploratory errors probe is much the same as there are no significant differences,
however the means of the control and CCI group on the day 10 probe trial (13.9 and
20.86, respectively) show some separation.
SECTION 4.3: DISCUSSION
While the total latency, escape percentages, and returns to goal probe show some
benefit to spatial learning and memory due to LIPOMA treatment, the high primary
latency and number of primary errors more closely follow those of the untreated CCI
group. These data suggest that LIPOMA has a neuroprotective effect; however, not a
large one. An accurate description of the level of neuroprotection LIPOMA was able of
achieving is highlighted in the probe trial returns to goal. While a significant difference

was found in the short-term between CCI and control, LIPOMA also outperforms the
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CCI group. In the long-term returns to goal probe, the control group outperformed both
the CCI and LIPOMA groups with the latter two groups performing similarly. However,
both the short-term CCI and LIPOMA difference and all long-term differences are not
significant, likely due to the high variability within both injured groups. One major
source of variability and something that is to be addressed in future work is the low
number of animals in each group. While the 10 for the controls was enough to see
differences in protocol comparisons, it is entirely possible that smaller differences, such
as those between CCI and LIPOMA treated animals, would be missed with only 7 and 9
animals, respectively. Additionally, impact depth in the CCI surgeries could be a factor as
well as the moderate-to-severe depth of 2.5 mm could lead to the full destruction of the
left hippocampus, an injury of which only the most substantial recovery would be
noticeable. While additional testing is needed to determine the extent of the benefit, these
results seem to suggest increased neuroprotection from intervention immediately after
injury. Indeed, the differences shown in escape frequency are enough to warrant further
investigation into not only LIPOMA, but other neuroprotective NPs as well.

CHAPTER 5: CONCLUSIONS
In this work, a MWM study was used as a benchmark to establish the base for
another spatial learning and memory paradigm capable of testing TBI. Two BM protocols
were established as potential replacement tests, allowing to control for the endogenous
anxiety which may have been a confounding factor in measuring both sex differences and
ensuring a large enough gap between control and injured animals that the effects of a NP

therapeutic could be accurately and measured. We developed and optimized a BM
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protocol based on a traditional protocol that has been highly characterized and widely
used. Our work utilizing the traditional protocol did not provide ample separation and
learning expected from what has been seen in various TBI literature and what was being
seen in the molecular and histological correlates from colleagues within the lab. Due to
these shortcomings, a novel, shortened BM protocol was established pulling from various
literature sources discussing the importance of increased trial number and a long-term
memory probe was added to determine if differences might occur there as well. While the
protocol has shown a mild neuroprotective effect with LIPOMA, the success of the BM
in this testing opens the ability for testing of other antioxidant NP therapeutics.
SECTION 5.1: SHORTCOMINGS
Behavior is highly variable and thus must be highly controlled to maintain consistency.
As seen in the trial results shown in Chapter 3, the variability between subjects can be
very high in injured animals resulting in a low statistical power. The most common
method of increasing power, increasing the number of animals tested in each group, is a
potential way of dealing with this issue; however, the length and speed at which
behavioral testing can be done is intrinsically slow. Another shortcoming of the updated
BM protocol is the removal of the reversal week and therefore the potential to test for
cognitive flexibility. While this is a shortcoming, it is less important in the current
research as our focus is purely on learning and memory for initial testing as it is more
important to establish a significant treatment effect before exploring other effects of NP
treatment. Another possible shortcoming of this work could be in the high variability in
CCI mice. This variability may be inherent due to injury and more testing is required to

determine the extent of this variability and how much it can be reduced. Indeed, while
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control mice have continuously smaller variability throughout the week, CCI mice seem
to have a relatively consistently high variability with, arguably, a slightly lower
variability by the end of the week due to the innate variability in individual reactions to
TBI and an inability to consolidate memory as efficiently as healthy mice.
SECTION 5.2: FUTURE WORK
Future work following the optimization of the protocol lies in four main areas and
several less directly important ones. Firstly, increasing the number of animals in each
group, especially the CCI and LIPOMA groups, can help to decrease variability and
establish outliers more consistently while inherently bringing down variability within the
injured groups. For example, from the returns to goal of this current data, we would need
16 mice in each group to notice differences between the CCI and LIPOMA groups at a
power of 80%. Alternatively, if we find a NP with stronger neuroprotective effects, NP
mice would need to average a latency of 6 seconds with the current amount of variability
and 17 mice in each group to see significant differences in primary latency with 80%
power. While this seems low, the current LIPOMA standard deviation is 26 seconds.
When compared to the control group at 10.3 seconds and the CCI group at 12.1 seconds,
LIPOMA variability is extremely high. If we assumed a similar variability to CCI,
approximately 13 seconds, NP treated mice would need to have an average primary
latency of 13.2 seconds, twice that of the control mice, with 14 mice in each group to see
significant differences against the untreated group at 80% power. All of these power
analyses were done using the short-term memory probe-trial. This highlights a further
need to understand the sources of increased variability of LIPOMA mice to determine if

this is the result of nonperformers or variability inherent to different reactions to
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LIPOMA. Second, expanding research into female mice can help to gain a further
perspective into a quickly growing realm of preclinical research aimed at increasing
clinical translation by introducing biological heterogeneity more similar to a clinical
population while still keeping many of the variables under control. This will also allow us
to identify any possible biological sex-based differences in antioxidant NP treatment
effects that exist. Third, lowering the injury severity may help in better assessing
therapeutic outcome as the immense damage caused by the tested injury depth may not be
able to translate into behavioral changes in the ways we would hope and expect from
other forms of NP efficacy testing. Finally, determining a quick and efficient method of
imaging to determine approximate injury depth is another primary focus to measure
injury variability and potentially rule out any injuries that fall outside the expected depth.
While this variability should be very small given the reproducibility of CCI, it is an
especially important to be precise and careful in behavioral testing with an already high
amount in innate variability.
Briefly, some additional areas of research important to the field lie in several
realms. Testing the effect of the therapeutic window on behavior seems to be an
important step forward after the main three areas of future work can be addressed.
Additionally, the development of a behavioral battery measuring deficits from the acute
to subacute to chronic phases of injury could be a beneficial method of categorizing
animals better to increase the ability of all behavioral tests in the battery to determine
deficits and assess how neuroprotective therapeutics may cause varying changes to
behavior dependent on the injury phase. Finding molecular correlates to spatial memory

consolidation may also be a promising area of study as recent work has pointed to
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potential sex-dependent differences in fear memory consolidation [74]. Understanding
those mechanisms may also open opportunities for therapeutic advancement that we have
not yet explored.

REFERENCES

57

[1] B.Z. McDonald, C.C. Gee, F.M. Kievit, The Nanotheranostic Researcher’s Guide for
Use of Animal Models of Traumatic Brain Injury, Journal of Nanotheranostics 2(4)
(2021) 224-268.
[2] A.I.R. Maas, D.K. Menon, P.D. Adelson, N. Andelic, M.J. Bell, A. Belli, P. Bragge,
A. Brazinova, A. Buki, R.M. Chesnut, G. Citerio, M. Coburn, D.J. Cooper, A.T.
Crowder, E. Czeiter, M. Czosnyka, R. Diaz-Arrastia, J.P. Dreier, A.C. Duhaime, A.
Ercole, T.A. van Essen, V.L. Feigin, G. Gao, J. Giacino, L.E. Gonzalez-Lara, R.L. Gruen,
D. Gupta, J.A. Hartings, S. Hill, J.Y. Jiang, N. Ketharanathan, E.J.O. Kompanje, L.
Lanyon, S. Laureys, F. Lecky, H. Levin, H.F. Lingsma, M. Maegele, M. Majdan, G.
Manley, J. Marsteller, L. Mascia, C. McFadyen, S. Mondello, V. Newcombe, A. Palotie,
P.M. Parizel, W. Peul, J. Piercy, S. Polinder, L. Puybasset, T.E. Rasmussen, R. Rossaint,
P. Smielewski, J. Soderberg, S.J. Stanworth, M.B. Stein, N. von Steinbuchel, W. Stewart,
E.W. Steyerberg, N. Stocchetti, A. Synnot, B. Te Ao, O. Tenovuo, A. Theadom, D.
Tibboel, W. Videtta, K.K.W. Wang, W.H. Williams, L. Wilson, K. Yaffe, T.P. In,
Investigators, Traumatic brain injury: integrated approaches to improve prevention,
clinical care, and research, Lancet Neurol 16(12) (2017) 987-1048.
[3] D. Najem, K. Rennie, M. Ribecco-Lutkiewicz, D. Ly, J. Haukenfrers, Q. Liu, M.
Nzau, D.D. Fraser, M. Bani-Yaghoub, Traumatic brain injury: classification, models, and
markers, Biochem Cell Biol 96(4) (2018) 391-406.
[4] J.B. Long, T.L. Bentley, K.A. Wessner, C. Cerone, S. Sweeney, R.A. Bauman, Blast
overpressure in rats: recreating a battlefield injury in the laboratory, J Neurotrauma 26(6)
(2009) 827-40.
[5] D.R. Namjoshi, W.H. Cheng, K.A. McInnes, K.M. Martens, M. Carr, A. Wilkinson, J.
Fan, J. Robert, A. Hayat, P.A. Cripton, C.L. Wellington, Merging pathology with
biomechanics using CHIMERA (Closed-Head Impact Model of Engineered Rotational
Acceleration): a novel, surgery-free model of traumatic brain injury, Mol Neurodegener 9
(2014) 55.
[6] A.C. McKee, D.H. Daneshvar, The neuropathology of traumatic brain injury, Handb
Clin Neurol 127 (2015) 45-66.
[7] J.A. Langlois, W. Rutland-Brown, M.M. Wald, The epidemiology and impact of
traumatic brain injury: a brief overview, J Head Trauma Rehabil 21(5) (2006) 375-8.
[8] K.J. Barnham, C.L. Masters, A.I. Bush, Neurodegenerative diseases and oxidative
stress, Nat Rev Drug Discov 3(3) (2004) 205-14.
[9] N. Khatri, M. Thakur, V. Pareek, S. Kumar, S. Sharma, A.K. Datusalia, Oxidative
Stress: Major Threat in Traumatic Brain Injury, CNS Neurol Disord Drug Targets 17(9)
(2018) 689-695.
[10] When Will a Clinical Trial for Traumatic Brain Injury Succeed?, 2016.
https://aansneurosurgeon.org/willclinical-trial-traumatic-brain-injury-succeed/. (Accessed
15 June 2021).
[11] R.B. Howard, I. Sayeed, D.G. Stein, Suboptimal Dosing Parameters as Possible
Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain
Injury, J Neurotraum 34(11) (2017) 1915-+.

58

[12] P.M. Kochanek, C.E. Dixon, S. Mondello, K.K.K. Wang, A. Lafrenaye, H.M.
Bramlett, W.D. Dietrich, R.L. Hayes, D.A. Shear, J.S. Gilsdorf, M. Catania, S.M.
Poloyac, P.E. Empey, T.C. Jackson, J.T. Povlishock, Multi-Center Pre-clinical Consortia
to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury:
Operation Brain Trauma Therapy and Beyond, Front Neurol 9 (2018) 640.
[13] B.Y. Gravesteijn, C.A. Sewalt, A. Ercole, C. Akerlund, D. Nelson, A.I.R. Maas, D.
Menon, H.F. Lingsma, E.W. Steyerberg, C. Collaborative European NeuroTrauma
Effectiveness Research for Traumatic Brain Injury, Toward a New Multi-Dimensional
Classification of Traumatic Brain Injury: A Collaborative European NeuroTrauma
Effectiveness Research for Traumatic Brain Injury Study, J Neurotrauma 37(7) (2020)
1002-1010.
[14] J.F. Malec, A.W. Brown, C.L. Leibson, J.T. Flaada, J.N. Mandrekar, N.N. Diehl,
P.K. Perkins, The mayo classification system for traumatic brain injury severity, J
Neurotrauma 24(9) (2007) 1417-24.
[15] C.N. Bodnar, K.N. Roberts, E.K. Higgins, A.D. Bachstetter, A Systematic Review of
Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats, J
Neurotrauma 36(11) (2019) 1683-1706.
[16] Y. Xiong, A. Mahmood, M. Chopp, Animal models of traumatic brain injury, Nat
Rev Neurosci 14(2) (2013) 128-42.
[17] J. Griffen, R. Hanks, Cognitive and Behavioral Outcomes from Traumatic Brain
Injury, Handbook on the Neuropsychology of Traumatic Brain Injury, Springer2014, pp.
25-45.
[18] J.D. Corrigan, Traumatic Brain Injury and Treatment of Behavioral Health
Conditions, Psychiatr Serv 72(9) (2021) 1057-1064.
[19] S.T. Fujimoto, L. Longhi, K.E. Saatman, V. Conte, N. Stocchetti, T.K. McIntosh,
Motor and cognitive function evaluation following experimental traumatic brain injury,
Neurosci Biobehav Rev 28(4) (2004) 365-78.
[20] R. Grandhi, S. Tavakoli, C. Ortega, M.J. Simmonds, A Review of Chronic Pain and
Cognitive, Mood, and Motor Dysfunction Following Mild Traumatic Brain Injury:
Complex, Comorbid, and/or Overlapping Conditions?, Brain Sci 7(12) (2017).
[21] R.J. Nudo, Recovery after brain injury: mechanisms and principles, Front Hum
Neurosci 7 (2013) 887.
[22] J. Sandry, K.S. Chiou, J. DeLuca, N.D. Chiaravalloti, Individual Differences in
Working Memory Capacity Predicts Responsiveness to Memory Rehabilitation After
Traumatic Brain Injury, Arch Phys Med Rehabil 97(6) (2016) 1026-1029 e1.
[23] O. Malkesman, L.B. Tucker, J. Ozl, J.T. McCabe, Traumatic brain injury - modeling
neuropsychiatric symptoms in rodents, Front Neurol 4 (2013) 157.
[24] Y.P. Zhang, J. Cai, L.B. Shields, N. Liu, X.M. Xu, C.B. Shields, Traumatic brain
injury using mouse models, Transl Stroke Res 5(4) (2014) 454-71.
[25] H.A. Miller, A.W. Magsam, A.W. Tarudji, S. Romanova, L. Weber, C.C. Gee, G.L.
Madsen, T.K. Bronich, F.M. Kievit, Evaluating differential nanoparticle accumulation
and retention kinetics in a mouse model of traumatic brain injury via K(trans) mapping
with MRI, Sci Rep 9(1) (2019) 16099.

59

[26] E.D. Hall, J.A. Wang, D.M. Miller, J.E. Cebak, R.L. Hill, Newer pharmacological
approaches for antioxidant neuroprotection in traumatic brain injury, Neuropharmacology
145(Pt B) (2019) 247-258.
[27] J.P. Muizelaar, Clinical trials with Dismutec (pegorgotein; polyethylene glycolconjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head
injury, Adv Exp Med Biol 366 (1994) 389-400.
[28] B. Alam Bony, F.M. Kievit, A Role for Nanoparticles in Treating Traumatic Brain
Injury, Pharmaceutics 11(9) (2019).
[29] A. Priester, R. Waters, A. Abbott, K. Hilmas, K. Woelk, H.A. Miller, A.W. Tarudji,
C.C. Gee, B. McDonald, F.M. Kievit, A.J. Convertine, Theranostic Copolymers
Neutralize Reactive Oxygen Species and Lipid Peroxidation Products for the Combined
Treatment of Traumatic Brain Injury, Biomacromolecules 23(4) (2022) 1703-1712.
[30] D. Yoo, A.W. Magsam, A.M. Kelly, P.S. Stayton, F.M. Kievit, A.J. Convertine,
Core-Cross-Linked Nanoparticles Reduce Neuroinflammation and Improve Outcome in a
Mouse Model of Traumatic Brain Injury, ACS Nano 11(9) (2017) 8600-8611.
[31] C.V. Vorhees, M.T. Williams, Assessing spatial learning and memory in rodents,
ILAR J 55(2) (2014) 310-32.
[32] J. Popovitz, S.P. Mysore, H. Adwanikar, Long-Term Effects of Traumatic Brain
Injury on Anxiety-Like Behaviors in Mice: Behavioral and Neural Correlates, Front
Behav Neurosci 13 (2019) 6.
[33] S.B. Juengst, L. Terhorst, C.L. Kew, A.K. Wagner, Variability in daily self-reported
emotional symptoms and fatigue measured over eight weeks in community dwelling
individuals with traumatic brain injury, Brain Inj 33(5) (2019) 567-573.
[34] S.H. Yang, J. Gustafson, M. Gangidine, D. Stepien, R. Schuster, T.A. Pritts, M.D.
Goodman, D.G. Remick, A.B. Lentsch, A murine model of mild traumatic brain injury
exhibiting cognitive and motor deficits, J Surg Res 184(2) (2013) 981-8.
[35] K. Gawel, E. Gibula, M. Marszalek-Grabska, J. Filarowska, J.H. Kotlinska,
Assessment of spatial learning and memory in the Barnes maze task in rodentsmethodological consideration, Naunyn Schmiedebergs Arch Pharmacol 392(1) (2019) 118.
[36] C.V. Vorhees, M.T. Williams, Morris water maze: procedures for assessing spatial
and related forms of learning and memory, Nat Protoc 1(2) (2006) 848-58.
[37] F.E. Harrison, A.H. Hosseini, M.P. McDonald, Endogenous anxiety and stress
responses in water maze and Barnes maze spatial memory tasks, Behav Brain Res 198(1)
(2009) 247-51.
[38] F. Morellini, Spatial memory tasks in rodents: what do they model?, Cell Tissue Res
354(1) (2013) 273-86.
[39] A.L. Shelton, S.A. Marchette, A.J. Furman, A Mechanistic Approach to Individual
Differences in Spatial Learning, Memory, and Navigation, Psychology of Learning and
Motivation, Academic Press, Cambridge, MA, 2013, pp. 223-259.
[40] R.W. Skelton, S.P. Ross, L. Nerad, S.A. Livingstone, Human spatial navigation
deficits after traumatic brain injury shown in the arena maze, a virtual Morris water maze,
Brain Inj 20(2) (2006) 189-203.
[41] T. Enomoto, T. Osugi, H. Satoh, T.K. McIntosh, T. Nabeshima, Pre-Injury
magnesium treatment prevents traumatic brain injury-induced hippocampal ERK

60

activation, neuronal loss, and cognitive dysfunction in the radial-arm maze test, J
Neurotrauma 22(7) (2005) 783-92.
[42] M.S. Shin, H.K. Park, T.W. Kim, E.S. Ji, J.M. Lee, H.S. Choi, M.Y. Kim, Y.P. Kim,
Neuroprotective Effects of Bone Marrow Stromal Cell Transplantation in Combination
With Treadmill Exercise Following Traumatic Brain Injury, Int Neurourol J 20(Suppl 1)
(2016) S49-56.
[43] S.B. Floresco, J.K. Seamans, A.G. Phillips, Selective Roles for Hippocampal,
Prefrontal Cortical, and Ventral Striatal Circuits in Radial-Arm Maze Tasks With or
Without a Delay, The Journal of Neuroscience 17(5) (1997) 1880-1890.
[44] H. Darwish, H. Hasan, Y-Shaped Maze to Test Spontaneous Object Recognition and
Temporal Order Memory After Traumatic Brain Injury, Methods Mol Biol 2011 (2019)
383-392.
[45] E.Y. Pioli, B.N. Gaskill, G. Gilmour, M.D. Tricklebank, S.L. Dix, D. Bannerman,
J.P. Garner, An automated maze task for assessing hippocampus-sensitive memory in
mice, Behav Brain Res 261 (2014) 249-57.
[46] Q. Zhang, Y. Kobayashi, H. Goto, S. Itohara, An Automated T-maze Based
Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free
Moving Rodents, J Vis Exp (138) (2018).
[47] K.E. Davis, K. Burnett, J. Gigg, Water and T-maze protocols are equally efficient
methods to assess spatial memory in 3xTg Alzheimer's disease mice, Behav Brain Res
331 (2017) 54-66.
[48] S.A. Farr, M.L. Niehoff, V.B. Kumar, D.A. Roby, J.E. Morley, Inhibition of
Glycogen Synthase Kinase 3beta as a Treatment for the Prevention of Cognitive Deficits
after a Traumatic Brain Injury, J Neurotrauma 36(11) (2019) 1869-1875.
[49] C.M. Bird, N. Burgess, Spatial Memory: Assessment in Animals, Encyclopedia of
Neuroscience2009, pp. 187-194.
[50] A. Wolf, B. Bauer, E.L. Abner, T. Ashkenazy-Frolinger, A.M. Hartz, A
Comprehensive Behavioral Test Battery to Assess Learning and Memory in
129S6/Tg2576 Mice, PLoS One 11(1) (2016) e0147733.
[51] B. Hattiangady, V. Mishra, M. Kodali, B. Shuai, X. Rao, A.K. Shetty, Object
location and object recognition memory impairments, motivation deficits and depression
in a model of Gulf War illness, Front Behav Neurosci 8 (2014) 78.
[52] R. Elliott, R.J. Dolan, Differential Neural Responses during Performance of
Matching and Nonmatching to Sample Tasks at Two Delay Intervals, The Journal of
Neuroscience 19(12) (1999) 5066-5073.
[53] J.K. Denninger, B.M. Smith, E.D. Kirby, Novel Object Recognition and Object
Location Behavioral Testing in Mice on a Budget, J Vis Exp (141) (2018).
[54] D.L. Brody, D.M. Holtzman, Morris water maze search strategy analysis in PDAPP
mice before and after experimental traumatic brain injury, Exp Neurol 197(2) (2006)
330-40.
[55] G. Iaria, M. Petrides, A. Dagher, B. Pike, V.D. Bohbot, Cognitive Strategies
Dependent on the Hippocampus and Caudate Nucleus in Human Navigation: Variability
and Change with Practice, The Journal of Neuroscience 23(13) (2003) 5945-5952.
[56] A. Can, D.T. Dao, M. Arad, C.E. Terrillion, S.C. Piantadosi, T.D. Gould, The mouse
forced swim test, J Vis Exp (59) (2012) e3638.

61

[57] R. Sunal, B. Gümüşel, S.O. Kayaalp, Effect of changes in swimming area on results
of “behavioral despair test”, Pharmacology Biochemistry and Behavior 49(4) (1994) 891896.
[58] M.L. Seibenhener, M.C. Wooten, Use of the Open Field Maze to measure locomotor
and anxiety-like behavior in mice, J Vis Exp (96) (2015) e52434.
[59] K.J. Osmon, M. Vyas, E. Woodley, P. Thompson, J.S. Walia, Battery of Behavioral
Tests Assessing General Locomotion, Muscular Strength, and Coordination in Mice, J
Vis Exp (131) (2018).
[60] J.M. Koolhaas, C.M. Coppens, S.F. de Boer, B. Buwalda, P. Meerlo, P.J.
Timmermans, The resident-intruder paradigm: a standardized test for aggression,
violence and social stress, J Vis Exp (77) (2013) e4367.
[61] T.R. de Jong, D.I. Beiderbeck, I.D. Neumann, Measuring virgin female aggression
in the female intruder test (FIT): effects of oxytocin, estrous cycle, and anxiety, PLoS
One 9(3) (2014) e91701.
[62] C.S. Mendes, I. Bartos, Z. Marka, T. Akay, S. Marka, R.S. Mann, Quantification of
gait parameters in freely walking rodents, BMC Biol 13 (2015) 50.
[63] M. Carter, J. Shieh, Chapter 2 - Animal Behavior, Guide to Research Techniques in
Neuroscience, Academic Press, San Diego, CA, USA, 2015, pp. 39-71.
[64] J.N. Crawley, What's Wrong With My Mouse?, 2007.
[65] E.A. Kappos, P.K. Sieber, P.E. Engels, A.V. Mariolo, S. D'Arpa, D.J. Schaefer, D.F.
Kalbermatten, Validity and reliability of the CatWalk system as a static and dynamic gait
analysis tool for the assessment of functional nerve recovery in small animal models,
Brain Behav 7(7) (2017) e00723.
[66] N. Burgess, E.A. Maguire, J. O'Keefe, The Human Hippocampus and Spatial and
Episodic Memory, Neuron 35(4) (2002) 625-641.
[67] Y. Shinohara, A. Hosoya, N. Yamasaki, H. Ahmed, S. Hattori, M. Eguchi, S.
Yamaguchi, T. Miyakawa, H. Hirase, R. Shigemoto, Right-hemispheric dominance of
spatial memory in split-brain mice, Hippocampus 22(2) (2012) 117-21.
[68] L.B. Tucker, A.G. Velosky, J.T. McCabe, Applications of the Morris water maze in
translational traumatic brain injury research, Neurosci Biobehav Rev 88 (2018) 187-200.
[69] A.W. Tarudji, C.C. Gee, S.M. Romereim, A.J. Convertine, F.M. Kievit, Antioxidant
thioether core-crosslinked nanoparticles prevent the bilateral spread of secondary injury
to protect spatial learning and memory in a controlled cortical impact mouse model of
traumatic brain injury, Biomaterials 272 (2021) 120766.
[70] T.G. Rubin, M.L. Lipton, Sex Differences in Animal Models of Traumatic Brain
Injury, J Exp Neurosci 13 (2019) 1179069519844020.
[71] P. Monfort, B. Gomez-Gimenez, M. Llansola, V. Felipo, Gender differences in
spatial learning, synaptic activity, and long-term potentiation in the hippocampus in rats:
molecular mechanisms, ACS Chem Neurosci 6(8) (2015) 1420-7.
[72] S. Safari, N. Ahmadi, R. Mohammadkhani, R. Ghahremani, M. Khajvand-Abedeni,
S. Shahidi, A. Komaki, I. Salehi, S.A. Karimi, Sex differences in spatial learning and
memory and hippocampal long-term potentiation at perforant pathway-dentate gyrus (PPDG) synapses in Wistar rats, Behav Brain Funct 17(1) (2021) 9.

62

[73] L.B. Tucker, A.G. Velosky, A.H. Fu, J.T. McCabe, Chronic Neurobehavioral Sex
Differences in a Murine Model of Repetitive Concussive Brain Injury, Front Neurol 10
(2019) 509.
[74] A. Florido, E.R. Velasco, C.M. Soto-Faguas, A. Gomez-Gomez, L. Perez-Caballero,
P. Molina, R. Nadal, O.J. Pozo, C.A. Saura, R. Andero, Sex differences in fear memory
consolidation via Tac2 signaling in mice, Nat Commun 12(1) (2021) 2496.

MWM

Behavioral
Task

Expected Result
(Compared to Control
Group)

TBI should spend less
time near the escape and
more time in quadrants
away from the escape

The percentage
of time spent
in a specific
quadrant over
the total time
in maze.
The percentage
of time spent
in the outer
annulus of the

Percent in
Quadrant (%
or fraction)

Percent of
Time in the
Outer Annulus
(% or fraction)

TBI should spend more
time in the outer
annulus

TBI should take longer

Latency to
Platform (s)

Spatial Learning and Memory

Description

The amount of
time it takes an
animal to
escape the
maze.

Data Type

Higher percentages in the
outer annulus show
thigmotaxis, which shows
no learning or confusion.

High percentages in the
quadrant of the platform
show higher learning;
however, high
percentages in the
reversal week in the
former escape quadrant
show an inability to
relearn.

Decreased latency shows
a higher amount of
spatial learning.

Meaning of Result

TA BLE 1. Key data generated from behavioral paradigms expected changes following TBI. Adapted from [1].
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MWM

Behavioral
Task

The length of the
path made while
moving through
the maze.
The distance,
measured every
few seconds or
milliseconds, from
the platform.

Latency
Path Length
(cm)

Cumulative
Distance
from the
Platform
(cm or m)

Expected Result
(Compared to
Control Group)

The angle between
the first movement
of the animal and
a direct line to the
platform.
The strategy (i.e.,
spatial, nonspatial,
or random) the
animal uses to find
the platform.

First
Bearing
(Degrees or
radians)

Search
Strategy

TBI should use
more random or
nonspatial
strategies

TBI should have
a larger degree of
first bearing

TBI should have
a larger
cumulative
distance

TBI should have a
large path length

Meaning of Result

Higher use of random search strategies indicates
lower learning and memory while the inverse of
higher spatial strategies shows an increase in
learning and memory.

Higher degree of first bearing shows a deficit in
memory of where the platform lies spatially.

Longer distances show a lack of spatial or nonspatial search strategies, which indicate worse
learning or memory.

Higher path length shows more movement and a
lower understanding of how to escape the maze
and thus, less ability to learn and memorize the
maze.

Spatial Learning and Memory

Description

Data Type

B

BM

MWM

Behavioral
Task

TBI should spend less
time in the target
quadrant

TBI should pass over
less

The time spent in
the quadrant where
the platform should
be as a percentage
of total time.

Probe Trial The number of times
Platform
the area where the
Crossings platform should be is
(Frequency)
passed over.
The velocity at
which animals are
travelling in the
maze
The amount of time
it takes an animal to
find the escape and
enter (head only).

Swim Speed
(m/s)

Primary
Latency (s)

TBI should take longer

TBI should be relatively
similar to rule out motor
deficits; however, this is
specific to post-acute
phase testing

Spatial Learning and Memory

Probe Trial
Time in
Target
Quadrant (%
or fraction)

Expected Result
(Compared to Control
Group)

Description

Data Type

Lower primary latencies show a better
understanding of the escape and how to
reach it via nonspatial navigation or spatial
navigation, depending on search strategy.

Lower swim speed shows either a motor
coordination deficit, or, potentially but
unlikely, a lower ability to learn and
remember the maze. These should, in most
circumstances, be very similar.

Higher frequency of platform crossing
shows better learning and memory.

Higher percentage of time in the target
quadrant shows an increased ability in
learning and memory of the maze.

Meaning of Result

C

BM

Behavioral
Task

The amount of time it takes
an animal to find and fully
enter the escape hole
The number of times an
animal enters a non-escape
hole with its head.

The number of times an
animal makes a reference
error after having visited
that hole before.
The number of times an
animal repeats searching the
same hole before moving on
t
th
The number of times an
animal enters a non-escape
hole with its head before
finding the escape hole.

Reference
Errors
(Frequency)

Working
Errors
(Frequency)

Perseverative Errors
(Frequency)

Primary
Errors
(Frequency)

Expected Result
(Compared to
Control Group)

TBI should have
more errors

TBI should have
more errors

TBI should have
more errors

TBI should have
more errors

TBI should take
longer

Spatial Learning and Memory

Description

Total
Latency (s)

Data Type

Higher perseverative errors show a lack of
learning and memory of places previously
visited and may, in reversal trials, indicate
i bilit t
l
Higher primary errors indicate deficits in
learning and memory of the maze.

Higher working errors show a decreased
understanding of the maze along with
potential confusion regarding visited areas,
showing a lack of memory.

Higher reference errors show a decreased
ability to learn and memorize the maze.

Lower total latency shows learning and
memory into which method will provide
escape the quickest.

Meaning of Result

D

BM

Behavioral
Task

The number of
non-escape hole
visits between
the first visited
hole and the
escape.
The distance an
animal has
travelled before
reaching the
escape hole with
only its head.

Primary
Path Length
(cm)

TBI should have a
longer distance

TBI should have a
higher score

Meaning of Result

Path length, in either context, shows a decreased
ability to understand and memorize the maze

Higher hole deviation scores show a lack of
learning and memory when related to finding the
correct path in the maze. Spatial learning will
show lower scores than nonspatial learning.

Higher total errors indicate deficits in learning
and memory of escape of the maze, or, when
combined with low primary latency, more
curiosity from the animals, indicating comfort in
the maze.

Spatial Learning and Memory

Expected Result
(Compared to
Control Group)

The number of TBI should have more
errors
times an animal
enters a nonescape hole with
its head before
entering the
escape hole with
its whole body.

Description

Hole
Deviation
Score

Total Errors
(Frequency)

Data Type

E

BM

Behavioral
Task

Expected Result
(Compared to
Control Group)

The distance an animal has
travelled before entering
the escape hole with its
whole body.
The strategy (i.e.,
direct/spatial, serial, or
mixed/random) the animal
uses to find the escape
hole.
The change in distance
over time at which animals
are travelling in the maze.

Search
Strategy

Velocity
(cm/s)

TBI should be
similar during
chronic phase, acute
phase measurements
may be lower for
TBI

TBI should use
more mixed/random
strategies and fewer
direct/spatial
strategies

TBI should have a
longer distance

Spatial Learning and Memory

Description

Total Path
Length (cm)

Data Type

Lower velocity can indicate motor
coordination issues within the maze.
These should stay relatively similar
throughout both weeks of trials.

Higher use of mixed/random search
strategies show a decreased ability to
learn the maze; however, an increase
in serial strategies after a large
number of spatial strategies show
complacency within the maze

Path length, in either context, shows a
decreased ability to understand and
memorize the maze.

Meaning of Result

F

RAM

Behavioral
Task

Expected Result
(Compared to
Control Group)

The time it takes for the animal to
first visit a baited or non-baited
food cup.

Non-baited
Arm Reentry
(Frequency)

Entry into an arm entered within
the test phase (delayed test only).

WithinPhase Error
(Frequency)
A second entry into an arm that had
been baited at the beginning of the
trial but was already discovered
(non-delayed test only).

Entry to an arm previously entered
during the training phase (delayed
test only).

AcrossPhase Error
(Frequency)

Baited Arm
Re-entry
(Frequency)

For delayed test, the number of
entries into non-baited arms. For
the non-delayed, re-entries into the
arms entered previously that trial.

Higher frequency shows a poor ability to
learn from the training phase and thus a
worse long-term memory
Higher frequency shows a poor ability to
remember what has been visiting, showing a
worse short-term memory

Higher re-entries of this type show a lack
of learning

Higher re-entries of this type show a lack
of memory.

TBI should have
more errors
TBI should have
more errors

TBI should have
more errors

Higher frequency of errors shows a lack of
memory.

Meaning of Result

TBI should have
more errors

TBI should have
more errors

Spatial Learning and Memory

Description

Errors
(Frequency

Data Type

G

T and Y
Maze

RAM

Behavioral
Task

Expected Result
(Compared to
Control Group)

The time it takes for the animal
to retrieve all food pellets.
The amount of time the animal
spends in the opened arm
during the second trial
(alternating T/Y maze only).
The percentage of animals that
enter the novel arm first during
the second trial (alternating T/Y
maze only).
When the entrance arm
direction is switched, the
animal will use spatial learning
and turn toward goal or
nonspatial learning and turn the
direction turned during training.

Time Spent
in Novel
Arm (% or
fraction)

Forced
Alternation
(% or
fraction)

Place Versus
Response
Learning

The time it takes for the animal
to first visit a baited or nonbaited food cup.

TBI should more
often use
nonspatial
learning and turn
in the direction it
did during training

TBI should enter
the novel arm less

This shows the difference between
place learning (spatial learning) and
response learning (nonspatial
learning).

A lower percentage of forced
alternation shows a lack of learning.

A lower percentage of time spent in
the novel arm shows memory deficits.

Higher total latency shows a lack of
learning and memory.

TBI should take
longer
TBI should spend
about equal time
exploring both
arms

Higher first latency shows a hesitancy
to explore the maze and potential
deficits in memory or learning. This
may also indicate a nonperformer.

Meaning of Result

TBI should take
longer

Spatial Learning and Memory

Description

Total
Latency (s)

First
Latency (s)

Data Type

H

Novel
Object
Recognition

Novel
Object
Location

Behavioral
Task

Expected Result
(Compared to
Control Group)

Discrimination
Index

Percent of Total
Investigation
Time (% or
fraction)

The time spent exploring the novel
location minus time spent
exploring the familiar location
divided by total time exploring
either object.

Discrimination
Index

The time spent exploring the novel
object minus time spent exploring
the familiar object divided by total
time exploring either object.

The time spent exploring the novel
object divided by the total time
spent in the exploring either object.

TBI should be closer
to zero; positive
values show more
time investigating
the novel object

TBI should spend
about 50% of the
time or less
exploring the novel
object

Nonspatial Learning and Memory

TBI should be closer
to zero; positive
values show more
time investigating
the novel location

The time spent exploring the novel
TBI should spend
location divided by the total time about 50% of the time
or less exploring the
spent exploring either object.
novel location

Spatial Learning and Memory

Description

Percent of Total
Investigation
Time (% or
fraction)

Data Type

A higher discrimination index
shows a preference to explore
the novel object rather than
the familiar object

A lower percentage of novel
investigation shows an
inability to remember the
familiar object.

A higher discrimination index
shows a preference to explore
the novel object rather than
the familiar object

A lower percentage of novel
investigation shows an
inability to remember the
familiar object.

Meaning of Result

I

The time spent not
attempting to climb,
move, or leave the
swimming column.
The time spent in either
the light or dark zones.
These will amount to
complimentary
measurements.
The distance travelled
while in either the dark
or light zone. This will
also contain two
separate data points for
light and dark zones.

Time
Spent
Immobile
(s)
Time
Spent in
Either
Zone
Distance
Travelled
in Each
Zone (cm)

Forced
Swim Test

Dark/Light
Avoidance
Test

Nonspatial variants
simply take away
spatial cues for each
task.

Same data
as
described
above

Nonspatial
Variants of
Spatial

Expected Result
(Compared to Control
Group)
Meaning of Result

TBI should travel a
greater distance in the
dark zone

TBI should spend more
time in the dark zone

TBI should spend a longer
time immobile; however,
depression-like activity is
still controversial

Emotional

Higher distance travelled in
the dark zone shows a higher
level of anxiety-like
behaviors, while a higher
distance travelled in the light
zone shows the inverse.

Longer time spent in the dark
zone shows a higher level of
anxiety-like behaviors, while
a longer time in the light zone
shows the inverse.

A longer time spent immobile
shows a larger number of
depressive-like symptoms.

Refer to above corresponding expectation for spatial tasks.

Nonspatial Learning and Memory

Description

Data Type

Behavioral
Task

J

Open Field
Test

Dark/Light
Avoidance
Test

Behavioral
Task

TBI should
have fewer
entries into the
light zone

The number of times an animal
enters and renters the light zone.

The amount of time the animal stays
on the outside of the open field,
measured either as seconds or as a
percentage or fraction of total time
spent in the open field.
The amount of time the animal
spends in the center of the open
field, measured either as seconds or
as a percentage or fraction of total
time spent in the open field.

Number of Entries
into the Light Zone
(Frequency)

Time Spent in the
Outer Zone (s or
%/fraction)

Time Spent in the
Central Zone (s
or %/fraction)

TBI should
spend less time
in the center
zone

TBI should
spend more
time in the
outer zone

TBI should take
longer to explore
the light zone

The amount of time it takes an
animal to first explore the light
zone.

Emotional

Description

Latency to Light
Zone (s)

Data Type

Expected
Result
(Compared to

A higher amount of time
spent in the central zone
shows a decrease in
anxiety-like responses.

A longer time spent in the
outer zone infers an
increased anxiety-like
response to the open field.

A lower number of entries
into the light zone shows an
increased amount of
anxiety-like behavior.

A greater latency to the
light zone shows an
increased amount of
anxiety-like behavior.

Meaning of Result

K

Resident
Intruder
Test

Open Field
Test

Behavioral
Task

The sum of social
exploration, genital
sniffing, and social
grooming.

Social
Explorati
on Score

TBI animals should
have lower social
exploration scores

A higher social exploration score shows a lower
level of anxiety.

A higher total offense score shows a higher level
of aggression.

TBI animals should
have higher total
offense scores

The sum of lateral
threat, upright standing,
clinch attacking,
keeping down the
intruder, and chasing.

Total
Offense
Score

Lower attack latencies show a higher aggression if
the animal attacking is the resident animal.

TBI should attack
earlier and usually
first

The amount of time
between introduction
and the first clinch
attack for either animal.

Meaning of Result

Attack
Latency
(s)

Emotional

Expected Result
(Compared to
Control Group)

The distance the animal Differences could be
Total distance travelled should, normally, be
from locomotor issues
travels through the
relatively similar. However, a greater total
or a greater stress
entire trial regardless of
distance travelled along with a significantly larger
zone.
response from a change time spent in the outer zone may show increased
in general activity. It is anxiety-like behaviors. Additionally, decreased
important researchers total distance travelled along with a significantly
take notice when using greater percentage of time spent in the center may
this measurement.
show a decrease in anxiety-like behaviors.

Description

Total
Distance
Travelled
(cm)

Data
Type

L

Footprint
Assay

Rotarod

Open Field
Test

Behavioral
Task

Step
Duration
(ms)

The length of
time one step
takes.

The distance
between steps of
the same paw.

Step Length
(mm)

Dependent on time;
TBI animals should
show differences
during acute and
subacute phases

Dependent on time;
TBI animals should
show differences
during acute and
subacute phases

A shorter step duration in the acute and subacute
phases shows poor motor coordination.

A shorter step length in the acute and subacute
phases shows poor motor coordination.

TBI animals should perform worse during the acute phase

The amount of
time it takes an
animal to fall off
of the rotating
rod.

Meaning of Result

Latency to
Fall (s)

Motor Coordination

Expected Result
(Compared to
Control Group)

The distance the TBI animals should Lower distance travelled can mean worse motor
animal travels
have less distance
coordination. See above for the relation between
through the entire
travelled. This is
total distance travelled and anxiety-like
behaviors. Time after injury is an important
trial regardless of mainly true for the
zone.
acute phase of injury.
parameter when interpreting these results.

Description

Total
Distance
Travelled
(cm)

Data Type

M

Footprint
Assay

Behavioral
Task

The coordination to
keep both legs on each
respective side within a
straight line. This
datum is quantitative.

Inter-Leg
Coordination

Expected Result
(Compared to
Control Group)
Dependent on time;
TBI animals should
show differences
during acute and
subacute phases

Motor Coordination

Description

Data Type

A worse outcome of inter-leg
coordination in the acute and subacute
phases shows poor motor coordination

Meaning of Result

N

